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Schizophrenia is a severe mental disorder affecting 0.5-1% of the population 
worldwide. The disorder is characterized by hallucinations, delusions, disorgani-
zed behavior and speech, avolition, anhedonia and flattened affect. The genetic 
etiology of the disorder is complex with evidence for multiple genes and path-
ways contributing to the onset of the disorder.
In the present study, we have studied one of the most promising candidate net-
works for schizophrenia, the DISC1 pathway in the Finnish population. We have 
utilized large Finnish samples; the schizophrenia family sample where DISC1 
was originally shown to associate with schizophrenia and the Northern Finland 
birth cohort 1966 (NFBC66).
Our findings significantly add up to the previous evidence for the involvement 
of DISC1 and the DISC1 pathway in the etiology of schizophrenia and psychosis. 
Our results support the concept of a number of DISC1 pathway related genes 
contributing in the etiology of schizophrenia along with DISC1 and provide new 
candidates for the studies of schizophrenia. Our findings also significantly inc-
rease the importance of DISC1 itself as having a role in psychological functio-
ning in the general population.
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Abstract 
Liisa Tomppo. The DISC1 Pathway in the Genetic Etiology of Schizophrenia. 
National Institute for Health and Welfare (THL), Research 37, 158 pages. Helsinki, 
Finland 2010. ISBN 978-952-245-315-0 (printed), ISBN 978-952-245-316-7 (pdf) 
  
Schizophrenia is a severe mental disorder affecting 0.5-1% of the population 
worldwide. The disorder is characterized by positive symptoms, such as 
hallucinations, delusions and disorganized behavior and speech, and negative 
symptoms including avolition, anhedonia and flattened affect. Genetic factors have 
shown involvement in the etiology of schizophrenia. Based on family, twin and 
adoption studies, hereditability estimates reach 83 %. The genetic etiology of the 
disorder is complex with evidence for multiple genes and pathways contributing to 
the onset of the disorder  
Many promising candidate genes for schizophrenia have been suggested. In 2000 a 
novel gene, Disrupted in Schizophrenia 1 (DISC1) was recognized at the 
translocation breakpoint between chromosomes 1 and 11 (t(1;11)(q42.1;q14.3)) in a 
large Scottish family with the high prevalence of schizophrenia and other psychiatric 
disorders. Since, DISC1 has emerged as one of the most promising candidate genes 
for schizophrenia and other psychiatric disorders based on linkage and association 
studies and animal models. DISC1 is also shown to associate with schizophrenia-
related cognitive, memory and neuroimaging phenotypes.  
DISC1 is a multifunctional hub for many protein interactions involved in 
intracellular several pathways. A number of genes encoding these proteins have also 
been identified as promising candidates for roles in the etiology of schizophrenia 
and other major mental illnesses. This has led to the DISC1 pathway concept: a 
hypothesis that proposes that the disruption of the pathways DISC1 is involved in 
contributes to risk of mental illnesses and that the disruption of DISC1 itself is only 
manner in which DISC1 pathways are affected.  
In the present study, we have studied the genes of the DISC1 pathway in the Finnish 
families ascertained for schizophrenia. We performed a DISC1 conditioned whole 
genome-wide linkage study hypothesizing that by conditioning for DISC1, we 
would be able to find new candidates for schizophrenia. We detected significant 
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linkage on a locus where DISC1 binding partner NDE1 is located. This finding was  
followed up and NDE1 displayed significant association with schizophrenia in the 
Finnish families.  
Encouraged by this finding, we proceeded to study other DISC1 binding partners. 
Along with NDE1, variants in NDEL1, PDE4B and PDE4D displayed significant 
association with schizophrenia. Additional evidence for these genes has been 
achieved in many other studies worldwide.  
Due to the abundance of evidence supporting the role for DISC1 in the etiologies of 
major mental illnesses, we wanted to study the impact of DISC1 at the population 
level. We studied intermediate phenotypes for psychosis in the large Northern 
Finland Birth Cohort 1966. We discovered that in the healthy general population 
variants in DISC1 that had previously shown evidence for association with both 
schizophrenia and bipolar disorder significantly associated with measures of 
anhedonia, a characteristic negative symptom of schizophrenia. 
Since the start of the present study, the number of genes implicated in the DISC1 
pathways has grown quickly. Variants in DISC1 and its binding partners have wide-
ranging effects on the expression of numerous genes that they do not even directly 
interact with. In the last part of this study, we used a conditioned genome-wide 
approach similar to that used in the discovery of NDE1 in order to recognize new 
variants contributing to the etiology of mental illnesses. We hypothesized that with 
the more homogeneous samples we would be more likely to identify variants that 
contribute in the etiology of schizophrenia dependent on DISC1. We conditioned a 
genome-wide association analysis on the DISC1 variants that previously associated 
with anhedonia. We found evidence for a DISC1-dependent association with 
biological relevance for schizophrenia between physical anhedonia and variants in 
CCDC141, LCT, MIR620 and MIR128-1. 
The present study supports the involvement of DISC1 and the DISC1 pathway in the 
etiology of schizophrenia and psychosis. The study also supports the theory of a 
complex genetic interplay in the genetic background of schizophrenia with multiple 
genes in the same pathways contributing both independently and dependently to 
schizophrenia risk. Based on the association with measures of anhedonia in the 
general population, the study also suggests that DISC1 and the DISC1 pathway 
might have general relevance in human psychological functioning. 
 
Keywords: schizophrenia, psychosis proneness, DISC1, DISC1 pathway, association, 
candidate gene, genetics / psychiatric genetics 
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Tiivistelmä 
Liisa Tomppo. The DISC1 Pathway in the Genetic Etiology of Schizophrenia 
[DISC1-polku skitsofrenian geneettisenä taustatekijänä]. Terveyden ja hyvinvoinnin 
laitos (THL), Tutkimus 37, 158 sivua. Helsinki  2010. ISBN 978-952-245-315-0 
(painettu), ISBN 978-952-245-316-7 (pdf)  
 
Skitsofrenia on vakava mielenterveyden häiriö, jota sairastaa 0.5-1 % väestöstä 
maailmanlaajuisesti. Skitsofrenian tyypillisiin oireisiin kuuluvat positiiviset oireet, 
joita ovat hallusinaatiot eli aistiharhat, harhaluulot, hajanainen puhe ja käytös sekä 
negatiiviset oireet, joita ovat kiinnostuksen puute, vähentynyt kyky tuntea mieli-
hyvää (anhedonia) sekä tunteiden ilmaisun köyhyys. Skitsofrenian on osoitettu 
johtuvan osittain geneettisistä tekijöistä. Perhe- ja kaksostutkimusten perusteella 
skitsofrenian periytyvyyden on arvioitu olevan jopa 83 %. Skitsofrenian geneettinen 
tausta on osoittautunut monitekijäiseksi. Todennäköisesti skitsofrenian puhkeami-
seen vaikuttavat useat geneettiset sekä ympäristötekijät yhdessä.  
Useita lupaavia skitsofrenialle altistavia ehdokasgeenejä on tunnistettu. Yksi lupaa-
vimmista ehdokasgeeneistä on DISC1 (Disrupted in Schizophrenia 1), joka tun-
nistettiin vuonna 2000, kun kromosomien yksi ja 11 välistä balansoitunutta trans-
lokaatiota tutkittiin. Tämä translokaatio, joka katkaisi sittemmin tunnistetun DISC1 
geenin, oli yhteydessä skitsofreniaan ja muihin mielenterveyden häiriöihin skot-
lantilaisessa suvussa. Sittemmin yhteys skitsofrenian ja DISC1-geenin välillä on 
osoitettu useissa geneettisissä assosiaatio- ja kytkentätutkimuksissa sekä eläinmal-
leissa ympäri maailman. DISC1 on yhteydessä myös skitsofreniaan liittyviin kogni-
tiivisiin ja muistiin liittyviin muuttujiin sekä näyttää olevan yhteydessä skitsofre-
niapotilaille tyypillisiin aivojen radiologisiin muutoksiin.  
DISC1 vuorovaikuttaa monien proteiinien kanssa osallistuen useiden aineenvaih-
duntapolkujen toimintaan. Monet geeneistä, jotka koodaavat DISC1:n kanssa vuoro-
vaikuttavia proteiineja ovat myös osoittautuneet lupaaviksi skitsofrenian ehdokas-
geeneiksi DISC1:n ohella. Tämä on johtanut DISC1 polku -käsitteen syntymiseen.  
Tässä tutkimuksessa kartoitimme DISC1 polun geenejä suomalaisessa perheai-
neistossa. Ehdollistamalla genominlaajuisen kytkentätutkimuksen DISC1:n riskiva-
riantille oletimme, että voisimme tunnistaa uusia skitsofrenian ehdokasgeenejä. 
Geneettinen lokus, jossa DISC1:n kanssa vuorovaikuttava NDE1 geeni sijaitsee, 
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osoitti merkittävää kytkentää. Tarkemmissa analyyseissä NDE1:n geenimerkit osoit-
tivat myös merkittävän yhteyden skitsofrenian ja tämän geenin välillä. Tämän löy-
döksen innoittamina kartoitimme yhteensä 11 muun DISC1:n kanssa vaikuttavan 
geenin yhteyttä skitsofreniaan. NDE1:n lisäksi, NDEL1, PDE4B ja PDE4D geenit 
osoittivat olevansa yhteydessä skitsofreniaan tässä suomalaisessa perheaineistossa. 
Sittemmin tukea näiden geenien ja skitsofrenian yhteydelle on löytynyt monissa 
tutkimuksissa ympäri maailman. 
Koska DISC1:n ja skitsofrenian väliselle yhteydelle on löytynyt paljon tukea, 
tahdoimme kartoittaa DISC1:n vaikutuksia väestötasolla. Tutkimme psykoosiin 
liittyviä ilmiasuja laajassa pohjoissuomalaisessa syntymäkohortissa vuodelta 1966. 
Havaitsimme DISC1:n liittyvän kyvyttömyyteen tuntea mielihyvää (anhedonia) 
myös terveessä väestössä. Anhedonia on myös yksi keskeinen skitsofrenian negatii-
visista oireista. 
Sen jälkeen, kun tämä tutkimus alkoi, DISC1 polulta tunnistettujen geenien määrä 
on kasvanut huomattavasti. Lisäksi on havaittu, että DISC1:n ja muiden DISC1 
polun geenien varianteilla on laajoja vaikutuksia useiden geenien ilmentymiseen, 
myös sellaisten geenien, jotka eivät suoraan vuorovaikusta DISC1 polun geenien 
kanssa. Tutkimuksen viimeisessä osassa kartoitimme uusia psykoosialttiuteen liitty-
viä muuttujia koko genomin laajuudelta. Tälläkin kerralla ehdollistimme tutkimuk-
sen aiemmin tunnistetuille DISC1 varianteille, kuten teimme tunnistaessamme 
NDE1 geenin. Tunnistimme variantteja kolmella geneettisellä alueella, jotka osoit-
tautuivat olevan yhteydessä anhedoniaan ja siten skitsofreniaan sekä assosiaatio- että 
biologisen tiedon perusteella. Nämä alueet sijaitsivat kromosomeissa kaksi (LCT, 
CCDC141 ja MIR 128-1) ja 12 (MIR620). 
Tutkimuksemme tukee DISC1:n ja DISC1 polun merkitystä skitsofrenian ja psy-
koosin taustatekijänä. Sen lisäksi, että DISC1:n vaikutus on havaittavissa väestö-
tasolla, onnistuimme tunnistamaan monia muita variantteja DISC1:een liittyvällä 
polulla. Osa tunnistamistamme varianteista näyttää itsenäisesti liittyvän skitso-
freniaan, osa vain ehdollistettuna DISC1:lle. Löydöksemme tukevat siten aiempaa 
käsitystä siitä, että skitsofrenian taustalla vaikuttaa laajamittainen yhteisvaikutus eri 
varianttien välillä. 
 
Avainsanat: skitsofrenia, skitsofrenian geneettinen tausta / genetiikka, DISC1, 
DISC1 polku, psykiatrinen genetiikka, assosiaatioanalyysi, ehdokasgeeni, psykoosi-
alttius 
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1 Introduction 
Schizophrenia is a severe, debilitating mental disorder affecting approximately 0.5-
1 % of the population worldwide.  Schizophrenia is a chronic disorder with onset in 
early adulthood. During its acute phase, schizophrenia causes remarkable reduction 
in cognitive abilities, psychological functioning and the sense of reality. The 
disorder causes severe disabilities in one’s social and professional lives and ability 
to care of one self. After the first episode at least 85 % of patients suffer a relapse 
within 5 years (Robinson et al. 2004). 
The etiology of schizophrenia is complex. Evidently several environmental factors 
contribute to its etiological background together with a large number of genes and 
genetic factors. The heritability of schizophrenia is estimated to be as high as 83 %, 
making the genetic component important (Cannon et al. 1998).   
Numerous promising candidate genes for schizophrenia have been recognized. One 
of the most successful findings has been the recognition of the DISC1-gene in early 
2000. The DISC1 gene codes a protein that functions as a hub for many intracellular 
processes. Numerous genes in DISC1-related pathways have been identified and 
many are good candidates for schizophrenia (Chubb et al. 2008).  
The role of the DISC1 locus has been studied in the Finnish population. DISC1 
displayed significant evidence for association and linkage with schizophrenia in 
Finnish families ascertained for schizophrenia (Hennah et al. 2003). DISC1 also 
associates with schizophrenia-related cognitive phenotypes, such as working 
memory and reduced gray matter volume, in the Finnish samples (Hennah et al. 
2005, Cannon et al. 2005). In addition, evidence suggesting the involvement of 
DISC1 in the etiologies bipolar disorder and autism spectrum disorders has been 
shown within Finnish population (Palo et al. 2007, Kilpinen et al. 2008).  
The present study has focused up on studying DISC1 and the genes involved in the 
DISC1 pathways in the Finnish population for additional evidence for their 
involvement in the etiology of schizophrenia.   
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2 Review of the literature 
2.1 Overview of schizophrenia 
Schizophrenia is a relatively common psychotic disorder characterized by various 
symptoms including hallucinations, delusions, apathy, social withdrawal and 
cognitive deficits. The symptoms result in radically impaired functioning in the 
affected individuals’ social and professional lives and ability to take care of 
themselves. Patients suffering from the condition are often incapable of work and 
often require inpatient treatment for extended periods of time (Sadock et al. 2005). 
Therefore, in addition to schizophrenia being life changing for both patients and 
their acquaintances, it puts a large burden on mental health services and the finances 
of healthcare systems (Mueser et al. 2004). 
2.1.1 Epidemiology 
The prevalence of schizophrenia is quite constant world-wide. In Finland, the life-
time prevalence of schizophrenia has shown to be 0.87 % (Perala et al. 2007). The 
incidence of the disorder in Finland is 0.41-0.53 new cases / 1000 individuals 
(Suvisaari et al. 1999). The disorder usually develops in early adulthood. The 
prevalence of the disorder is similar in both sexes, but onset typically occurs later 
among females. Onset usually takes place ages 20-28 years among males and ages 
24-31 years among females (Loranger 1984). Among females the course of the 
disorder tends to be more benign than in male patients (Mueser et al. 2004).  
2.1.2 Clinical features and diagnosis 
The clinical manifestations of schizophrenia are diverse. The disorder usually starts 
to develop with prodromal symptoms. This is a heterogeneous group of symptoms 
that include: changes in mood; depression; peculiar feelings and thoughts; 
aggressiveness; sleeping problems; problems in professional and social situations; 
and inability to concentrate. These symptoms are observed in 75 % of individuals 
who later develop schizophrenia, and thus they have predictive value for psychosis. 
However, these symptoms are often moderate and are normal among young adults 
(Salokangas et al. 2008). 
The actual symptoms of schizophrenia can be divided into three dimensions. These 
include positive symptoms, negative symptoms and cognitive impairment (Mueser 
et al. 2004)  
The typical, psychotic symptoms are referred as positive symptoms, which include 
hallucinations, delusions and disorganized or catatonic behavior. Hallucinations in 
schizophrenia are typically auditory hallucinations but visual, olfactory, gustatory 
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and tactile hallucinations occur as well. Delusions are commonly persecutory 
delusions, delusions of control, grandiose delusions or somatic delusions. The 
severity and the duration of positive symptom episodes usually vary (Mueser et al. 
2004, Tandon et al. 2009)  
Negative symptoms include flattening of speech and affect, avolition (lack of 
initiative or motivation) and anhedonia (inability to experience pleasure). Negative 
symptoms are more pervasive than the positive symptoms (Mueser et al. 2004, 
Tandon et al. 2009, Yung et al. 1996). The predominance of negative symptoms in 
the acute phase of the disorder has been connected with poorer recovery rates in the 
future (Thoma et al. 2005). 
Cognitive impairment comprises disturbances in memory functions, attention and 
executive functions. Cognitive abilities often decline rapidly right before and after 
the onset of the disorder, stabilizing at a level lower than that of the premorbid state. 
In the best case scenario, with good response to the treatment, cognitive functions 
might slightly improve in time (Mueser et al. 2004, Tandon et al. 2009).  
After the first acute (psychosis) period, approximately 90 % of patients suffer one or 
more relapses later in life. Cognitive and negative symptoms usually persist for 
months or years. Thus, schizophrenia is often a chronic disease (Mueser et al. 2004, 
Tandon et al. 2009). 
Schizophrenia diagnoses are based on either the International Classification of 
Diseases (ICD), currently tenth edition (ICD-10) (World Health Organization 1992) 
or Diagnostic and Statistical Manual for Mental Disorders (DSM), currently fourth 
edition (DSM-IV or DSM-IV-TR) (American Psychiatric Association 1994). A new 
revision of the DSM (DSM-V) is expected to be published in May 2013 
(http://www.dsm5.org/Pages/Default.aspx). Classifications by the two systems 
concur and essentially the two differ only in their semantics (Jager et al. 2004).  
According to the DSM-IV criteria (Table 1), the characteristic symptoms of 
schizophrenia have to be present for at least one month before a diagnosis can be 
made. Some signs of the disorder, such as prodromal and residual symptoms and 
disabilities in one’s social and professional lives, must be apparent for at least six 
months.   
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Table 1. Diagnostic criteria, DSM-IV 
A. Characteristic symptoms: Two (or more) of the following, each present for a 
significant portion of time during a 1-month period (or less if successfully treated): 
 delusions 
 hallucinations 
 disorganized speech (e.g., frequent derailment or incoherence) 
 grossly disorganized or catatonic behavior 
 negative symptoms, i.e., affective flattening, alogia, or avolition 
Only one Criterion A symptom is required if delusions are bizarre or hallucinations 
consist of a voice keeping up a running commentary on the person's behavior or 
thoughts, or two or more voices conversing with each other. 
B. Social/occupational dysfunction: For a significant portion of the time since the onset 
of the disturbance, one or more major areas of functioning such as work, interpersonal 
relations, or self-care are markedly below the level achieved prior to the onset (or 
when the onset is in childhood or adolescence, failure to achieve expected level of 
interpersonal, academic, or occupational achievement). 
C. Duration: Continuous signs of the disturbance persist for at least 6 months. This 6-
month period must include at least 1 month of symptoms (or less if successfully 
treated) that meet Criterion A (i.e., active-phase symptoms) and may include periods of 
prodromal or residual symptoms. During these prodromal or residual periods, the signs 
of the disturbance may be manifested by only negative symptoms or two or more 
symptoms listed in Criterion A present in an attenuated form (e.g., odd beliefs, unusual 
perceptual experiences). 
D. Schizoaffective and Mood Disorder exclusion: Schizoaffective Disorder and Mood 
Disorder With Psychotic Features have been ruled out because either (1) no Major 
Depressive Episode, Manic Episode, or Mixed Episode have occurred concurrently with 
the active-phase symptoms; or (2) if mood episodes have occurred during active-phase 
symptoms, their total duration has been brief relative to the duration of the active and 
residual periods. 
E. Substance/general medical condition exclusion: The disturbance is not due to the 
direct physiological effects of a substance (e.g., a drug of abuse, a medication) or a 
general medical condition. 
F. Relationship to a Pervasive Developmental Disorder: If there is a history of Autistic 
Disorder or another Pervasive Developmental Disorder, the additional diagnosis of 
Schizophrenia is made only if prominent delusions or hallucinations are also present for 
at least a month (or less if successfully treated). 
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2.1.3 Etiology 
The etiology of schizophrenia is complex, which means that both genetic and 
environmental factors play roles in the etiology of schizophrenia. If a close relative 
is affected with the disorder, the risk of developing schizophrenia is much higher 
than in the general population. If one’s sibling is affected with schizophrenia the risk 
for developing the disorder is 9 %. Furthermore, if ones monozygotic twin is 
affected the risk is up to 46 % (Figure 1) (Tsuang 2000). Based on twin, family and 
adoption studies, the genetic component in the etiology of schizophrenia is strong. In 
a large Finnish population-based twin study, the heritability was estimated to be     
83 % (Cannon et al. 1998). The remaining prevalence is thought to be explained by 
environmental factors.  Currently, it is thought that risk of developing schizophrenia 
is inherited and the time until onset is dependent on environmental factors (Mueser 
et al. 2004). 
 
 
 
Figure 1. Morbid risks for schizophrenia. Adapted from Tsuang et al. 2000. 
 
2.1.3.1 Neurodevelopmental hypothesis 
Schizophrenia is considered a neurodevelopmental disorder in which brain 
development is disturbed. Schizophrenia patients exhibit minor abnormalities in 
brain architecture and function. The changes in brain structure are not localized in 
any specific brain region and are detected at numerous locations. As a result, a 
concept of schizophrenia as a disease of neuronal connectivity has emerged (Fatemi 
et al. 2009).   
The neuronal migration and neuron development occurring during the embryonic 
period are disturbed at patients with schizophrenia. The development of the central 
nervous system is active during childhood when neuronal out-branching and the 
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formation of new synaptic connections take place. Interneuron deficits are thought to 
play important roles in the pathophysiology of schizophrenia (Lewis et al. 2005, 
Lisman et al. 2008, Jaaro-Peled et al. 2009). Postmortem studies of schizophrenia 
patients’ prefrontal cortexes show reductions in GABAergic interneurons (Beasley 
et al. 1997). The altered maturation of the mesocortical dopaminergic projection is 
suggested to contribute to the etiology of schizophrenia. Cortical dopamine is 
suggested to mediate proper information processing and working memory, which 
are impaired in patients with schizophrenia. Dopaminergic projections from the 
ventral tegmental area (VTA) to the cortex exhibit marked postnatal maturation 
(Jaaro-Peled et al. 2009, Rosenberg et al. 1995, Tseng et al. 2007, Egan et al. 2001). 
During puberty, a large amount of excess neuronal connections are destroyed 
(pruning). Subsequently, the reformation capacity of the brain is greatly decreased 
and minor brain abnormalities might become evident if alternative connections are 
destroyed. This may explain why schizophrenia often occurs during youth and early 
adulthood (Fatemi et al. 2009). 
Myelination of the cortex occurs postnatally and normally continues until young 
adulthood, but possibly even longer. Post mortem studies of schizophrenia patients 
show abnormalities in brain white matter tracts including corpus callosum, anterior 
commissure and fornix. A decreased number of oligodendrocytes are reported in the 
cortex and thalamic nucleus, and myelin abnormalities or apoptotic 
oligodendrocytes in prefrontal regions (Jaaro-Peled et al. 2009, Fields 2008). 
Individuals who are affected with schizophrenia have shown in some studies to have 
neuromotor, language and cognitive developmental deficits already in childhood. 
These developmental deficits are thought to be genetically programmed, consistent 
with the concept of schizophrenia as a neurodevelopmental disorder (Jones 1991).  
Furthermore, altered brain pathophysiology supports the role of neuronal changes in 
the etiology of schizophrenia. Brain abnormalities have been reported in the 
dorsolateral prefrontal cortex, hypothalamus and in different cortical areas. These 
changes include enlargement of the lateral and third ventricles and reduced gray 
matter volume, especially in the dorsolateral prefrontal cortex (DLPFC) (Fatemi et 
al. 2009). Dendritic changes and smaller cell soma have also been observed in 
patients with schizophrenia (Jaaro-Peled et al. 2009, Glantz et al. 2000, Selemon et 
al. 1999). 
2.1.3.2 Environmental factors 
The most studied environmental factors contributing to the onset of schizophrenia 
are prenatal factors. Stress on the fetus is a risk factor for schizophrenia. Such stress 
can be caused by infections, the toxic effects of alcohol and drug abuse, and 
inefficient nutrition among other factors. Complications during the delivery have 
also been linked to elevated risk of developing schizophrenia. In addition to 
schizophrenia, these factors predispose to other disorders including mood disorders, 
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antisocial personality disorder, learning problems and minimal brain dysfunction 
(syndrome) (Fatemi et al. 2009).   
Influenza, retrovirus, rubella and toxplasma gondii infections have been implicated 
in neuronal development problems and schizophrenia. Viral infections have at least 
two mechanisms through which they can affect the fetus, and thus affect neuronal 
development. Some infections are transmitted to and infect the fetus via the 
placenta, such as infection by the influenza A virus. This can result in altered DNA 
methylation patterns causing permanent gene expression modifications. The 
influenza A virus also induces the production of systemic cytokines in the maternal 
immune system, placenta and fetus, which can result in brain morphology changes 
(Fatemi et al. 2009).  
In addition to prenatal causes, many factors in childhood and youth environments 
are proposed to contribute to the risk. These include growing up in a dysfunctional 
family (Wahlberg et al. 1997), an urbanised area or a minority ethnic group (van Os 
et al. 2009). The use of cannabis and other drugs are suggested to elevate the risk of 
schizophrenia (van Os et al. 2009). Based on adoption studies, individuals at high 
genetic risk are more sensitive to problems in the rearing environment than 
individuals having lower genetic risk (Wahlberg et al. 1997, Tienari et al. 2004). 
Therefore, environmental stressors are thought to have a particularly deleterious 
effect on those individuals with a genetic diathesis or predisposition to a particular 
psychopathology (Tienari et al. 2004). 
2.1.3.3 Genetic factors 
The search for schizophrenia’s genetic component has been ongoing for decades. 
Despite hard work, no unambiguous variants or risk factors have been recognized. 
Currently, it is thought that the genetic component in the etiology is complex 
meaning that multiple genes together with environmental factors contribute to the 
onset and clinical picture.  
Genetic risk factors for schizophrenia will be discussed in more details in Chapter 
2.5 Genetics of schizophrenia. 
2.1.4 Link between schizophrenia and other mental and neurodevelopmental 
illnesses 
Schizophrenia is one of many in the wide spectrum of psychotic disorders. Other 
disorders where psychosis is a characteristic symptom are schizophrenia spectrum 
disorders: schizoid; schizotypal and paranoid personality disorders; 
schizophreniform; delusional and brief psychotic disorder; and psychosis not 
otherwise specified. Schizoaffective disorder is a mood disorder with psychotic 
features. Bipolar disorder and major depression might also include psychotic 
symptoms.  
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In families with patients suffering from schizophrenia, other mental illnesses also 
occur more frequently than in the general population. It has been shown in a Finnish 
adoptee study that in families ascertained for schizophrenia, the genetic liabilities for 
both schizoaffective disorder and schizophrenia spectrum disorders are elevated 
(Tienari et al. 2003). Liability for bipolar affective disorder or major depression was 
not significantly elevated even though they show some overlap in the genetic risk 
(Blackwood et al. 2007, Shifman et al. 2004). This suggests that schizophrenia; 
schizoaffective disorder and schizophrenia spectrum disorders share a common 
genetic background that predisposes to all these disorders (Tienari et al. 2003, 
Blackwood et al. 2007, Shifman et al. 2004).  
 Because of the evidence for the shared genetic factors underlying schizophrenia, 
bipolar disorder and other psychotic disorders, van Os and Kapur suggested in their 
recent review the usage of dimensional indicators across diagnostic categories (van 
Os et al. 2009). They suggested five main dimensions (psychosis, negative 
symptoms, cognitive symptoms, mania and depression).  
Schizophrenia might also share common liability with other disorders. Patients with 
schizophrenia and autism spectrum disorders have been reported to have similarities 
in the altered brain development (van Os et al. 2009). Evidence also suggests that 
part of the genetic liability might be shared with autism since common genes 
associate with both of these disorders such as DISC1 and PDE4B (Kilpinen et al. 
2008, Braun et al. 2007).  
2.1.5 Endophenotypes and other alternative phenotypes for schizophrenia 
Endophenotypes are intermediate factors between the clinical phenotype and the 
genotype. These are often used when studying the genetics of complex traits such as 
schizophrenia, because endophenotypes are presumed to have more straightforward 
genetic causes than the actual disease phenotype. There are several criteria that an 
endophenotype has to meet. Endophenotypes must be traits that are associated with 
the disorder in the population, present in everybody (including the healthy 
individuals), and are significantly heritable. Endophenotypes must co-segregate with 
the disorder in families and manifest at higher rate in the family members of affected 
individuals than in the general population (Gottesman et al. 2003, Braff et al. 2007).  
The cognitive deficits schizophrenia patients suffer from provide many phenotypes 
that can be measured using neuropsychological test batteries. These traits include 
working memory, verbal memory, attention, information processing, executive 
functions and sensory gating-related phenotypes (Heinrichs et al. 1998). These 
cognitive features also appear in milder forms among the healthy relatives of the 
patients (Hoti et al. 2004) and are heritable (Tuulio-Henriksson et al. 2002, 
Greenwood et al. 2007). Therefore, they are valid endophenotypes for schizophrenia 
and also other psychotic disorders (Gur et al. 2007, Antila et al. 2007). 
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Electrophysiological measures of brain activity are also endophenotypes for 
schizophrenia. Such measures are event-related potentials P50 and P300, which 
reflect deflections occurring 50 and 300 ms after auditory stimuli, respectively 
(Bramon et al. 2004, Patterson et al. 2008). Endophenotypes for schizophrenia also 
include the cerebral radiological measures: cortical grey matter volume; inter- and 
intrahemispheric white matter volume; and volume of the brain ventricle (Cannon et 
al. 2002, Tanskanen et al. 2008). 
In addition to the above mentioned verified endophenotypes, other intermediate 
phenotypes for schizophrenia and psychosis exist. These phenotypes have not been 
studied extensively enough to meet the strict criteria of endophenotypes. 
Many measures have been suggested as indicators of psychosis vulnerability or 
proneness to psychosis. Using these measures, it might be possible to identify 
individuals from the healthy population who have a high risk of schizophrenia. Such 
measures are, for example, the Psychosis Proneness Scales developed by Chapman 
and colleagues (Chapman et al. 1995). The scales measure properties that are 
observed at different levels in the healthy population and correspond to positive and 
negative aspects of psychosis. Patients suffering from schizophrenia score higher 
than healthy individuals. The scales also vary throughout the clinical state (Horan et 
al. 2008). They include measures of anhedonia (Physical Anhedonia Scale and 
Social Anhedonia Scale), which correlate with the negative aspects of schizophrenia. 
The positive aspects of schizophrenia are measured with the Perceptual Aberration 
Scale, the Magical Ideation Scale (Horan et al. 2008) and the Schizoidia Scale  
(Golden et al. 1979). 
A number of these scales have their heritability studied. The range of reported 
heritability estimates for the studied measures are: Revised Physical Anhedonia 
Scale 0.35-0.57 (MacDonald et al. 2001, Miller 1994), Revised Physical Anhedonia 
Scale 0.27-0.67 (MacDonald et al. 2001, Miller 1994, Kendler et al. 1991), 
Perceptual Aberration Scale 0.32-0.40 (MacDonald et al. 2001, Miller 1994). One 
report concluded familial resemblance of Perceptual Aberration Scale results from 
shared environmental factors only (Kendler et al. 1991).  Many of these scales 
already fulfill many of the criteria of an endophenotype and further studies may 
validate them as valid endophenotypes for schizophrenia. 
2.1.6 Treatment 
The key component of schizophrenia treatment is antipsychotic medication. 
Antipsychotic drugs can be divided into typical or first-generation antipsychotics 
(for example haloperidol) and atypical or second-generation antipsychotics (such as 
risperidone, olanzapine, clozapine and quetiapine). All antipsychotic drugs block 
dopamine (D2) receptors in the brain and second-generation antipsychotics have 
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effects on serotonin receptors as well (5HT-2A, 5HT-2C, 5HT-1A). Atypical 
antipsychotics are currently the most used in the treatment (Salimi et al. 2009) 
Antipsychotic medication usually lessens positive symptoms effectively but has less 
effect on the negative and cognitive symptoms (Salimi et al. 2009, Keefe et al. 
2007). Schizophrenia usually requires medical treatment for months or years. Many 
patients suffer from various side effects of the medication and a large number of 
them discontinue their medication as a result. Unfortunately many patients do not 
respond to treatment (Gerretsen et al. 2009).  
In addition to medical intervention, different psychosocial therapies are used 
(Mueser et al. 2004, Kern et al. 2009). Psychosocial intervention seeks to improve 
the management of schizophrenia and to enhance functioning in areas such as 
independent living, relationships and work. Specific interventions that have been 
shown to improve the outcome of schizophrenia include assertive community 
treatment, family psychoeducation, supported employment, social skills training, 
teaching illness management skills, cognitive- therapy for psychosis and integrated 
treatment for comorbid substance abuse (Mueser et al. 2004, Kern et al. 2009). 
 
2.2 The human genome 
2.2.1 Overview of the genome 
The human genome comprises about 3.2 billion base pairs (bp) divided into 23 
chromosome pairs of nuclear DNA and a small 16.5 kilobase (kb) ring of 
mitochondrial DNA (mtDNA). One half of the nuclear DNA is inherited from the 
mother and the other half from the father. The mitochondrial DNA is inherited 
solely from the mother (International Human Genome Sequencing Consortium 
2004). 
The genetic code of the DNA is determined by the organization of four different 
nucleobases on a DNA strand; adenine (A), cytosine (C) guanine (G) and thymine 
(T).  
2.2.2 Gene structure and function 
A gene has been traditionally defined as a sequence of DNA that codes for a mRNA 
molecule which is translated into a protein that has an impact on a phenotype (Wain 
et al. 2002). The human genome is estimated to include 21 000 protein coding genes 
of an average size of 10-15 kilobase (kb) (International Human Genome Sequencing 
Consortium 2004, Clamp et al. 2007). However, this definition has proven too 
narrow, in scope to encompass many newly discovered functional products coded by 
DNA sequences. According to a recently suggested definition, a gene is a sequence 
of DNA that codes for a functional molecule, either a protein or a RNA (Gerstein et 
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al. 2007). The DNA encoding several functional products might have overlapping 
regions of DNA sequence. A gene is, therefore, a union of DNA sequences encoding 
a coherent set of potentially overlapping functional products (Gerstein et al. 2007). 
The non-coding genes include micro-RNAs (miRNA) and small interfering RNAs 
(siRNA) (Gerstein et al. 2007). These carry out many regulatory functions and in 
this way have an impact on gene expression. The miRNAs are small molecules, 
approximately 20-24 nucleotides long. They are partially complementary to mRNA 
and can bind to it. By binding to mRNA, miRNAs regulate the expression of their 
target genes. Usually miRNAs have hundreds of target molecules (Bartel 2004). 
Like miRNAs, siRNAs are short double stranded molecules which abolish the 
function of mRNA to which they are homologous (Ghildiyal et al. 2009). Non-
coding RNAs also includes tRNA, rRNA (ribosomal RNA), small nuclear RNA 
(snRNA) and small nucleolar RNA (snoRNA) coding regions (Eddy 2001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. The schematic describes the structure of a DNA strand and its 
packing into chromosomes. Human DNA is organized into 23 chromosome 
pairs, which are located in the cell nucleus. A certain sequence of DNA coding a 
protein is called a gene. The transcription region of a gene comprises of exons 
and introns. Adapted from National Institutes of Health. National Human 
Genome Research Institute. “Talking Glossary of Genetic Terms.” 
http://www.genome.gov/glossary/.  
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2.2.3 Variation within the human genome 
Approximately 99.9 % of the human genome is shared among all individuals 
(Przeworski et al. 2000, Reich et al. 2002). The small portion not shared is 
responsible for all the variation existing among individuals.  
Several types of variation exist within the genome. Variation occurring in the non-
coding regions may have no effect on phenotypes. Variation in coding regions, on 
the other hand, can cause phenotypic differences.  
Variation arises in two settings: in the recombination of DNA during meiosis in 
germ cells, or as a result of structural or sequence mutations occurring at any time 
point in any cell. Recombination is the main driver of variation transferred to 
offspring. The further away two genetic loci are on a chromosome, the more likely a 
recombination even occurs between the two loci. The distance along a chromosome 
in which a recombination is statistically likely to occur is called Morgan. However, 
in genetic analyses the smaller subunit centiMorgan (cM) is used, which 
corresponds to a 1 % chance of change by recombination (Barzel et al. 2008).  
2.2.3.1 Structural variation 
Structural variation is often defined as genomic variation involving DNA segments 
larger than one kb (Feuk et al. 2006). The types of structural variation are deletions, 
inversions, duplications and translocations. Structural mutations can be due to the 
disrepair of chromosome breaks and the malfunction of the recombination system.  
Recombination occurs during meiosis when the double helix of DNA breaks in one 
maternal and one paternal chromatid, and the ends are switched between maternal 
and paternal chromatids. Recombination may result in abnormal recombinations of 
DNA. Recombination might also occur between chromatids of different 
chromosomes. If both recombinant chromatids end up in the same daughter cell 
during meiosis, the amount of chromosomal material remains the same in the cell. 
This type of translocation is called a balanced translocation. An unbalanced 
translocation occurs when chromatids with translocated material are directed into 
different daughter cells. In this situation, the chromosome material is either inflated 
or reduced with respect to the normal amount. Balanced translocations usually do 
not result in aberrant phenotypes. However, a few exceptions are important. If a 
translocation occurs within a gene or in close proximity of one, a disruption in the 
function of this gene might occur (Coop et al. 2007).  
Insertions, duplications and deletions over one kb in size differing in copy numbers 
with respect to the reference sequence are called copy number variations (CNV). 
This variation often occurs in the repetitive intronic elements of genes. If a CNV is 
present at a frequency > 1 % in a population, it is called a copy number 
polymorphism (Stankiewicz et al. 2010).  
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2.2.3.2 Sequence variation 
In addition to structural variation, a large amount of small scale variation exists 
within the genome. These can be divided into mutations and polymorphisms. In 
general, mutation refers to variation that alters a phenotype. Polymorphisms are 
thought to be functionally neutral (Frazer et al. 2009), but the nomenclature is not 
formally standardized. Small scale variation consists of base substitutions, insertions 
and deletions. Base substitution is usually found at a single base, but also as a cluster 
of nucleotides. In deletions, one or more nucleotides are missing from a sequence. 
Insertions appear when one or more extra nucleotides are found in a sequence. Small 
scale variation in the population tends to be inherited, but in some cases they can 
result from new mutations (de novo mutations) (Strachan et al. 2004).  
Microsatellites are short tandem repeats of DNA. Dinucleotide repeats are the most 
common in the genome, for example (CA/GT)*n. The lengths of these repeats often 
vary between individuals.  
Allelic sequence variation that occurs in a significant part of the population (usually 
> 1%) is called a polymorphism. The most common type of polymorphisms is single 
nucleotide polymorphisms (SNPs), which are single nucleotides that frequently 
differ between individuals. Insertions and deletions of one nucleotide are also 
considered SNPs (Strachan et al. 2004). Over 14 000 000 polymorphic nucleotides 
have currently been validated (NCBI dbSNP build 131, validated SNPs, 
http://www.ncbi.nlm.nih.gov/projects/SNP). 
Whether SNPs or other mutations have an impact on the phenotype is dependent on 
the site of the mutation or the polymorphism. In a protein coding region, a mutation 
might cause a codon change. If the codon change also causes an amino acid change, 
the mutation is denoted as a nonsynonymous mutation. Nonsense mutations occur 
when an amino acid coding codon is replaced by a stop codon. If the mutation in a 
codon causes no change in the amino acid, the mutation is called a synonymous or 
silent mutation (Strachan et al. 2004).  
Mutations in non coding regions have a potential impact on protein coding. Most 
notably, deletions and insertions can cause a shift in a translational reading frame 
resulting in a premature termination codon or loss of gene expression (Strachan et al. 
2004). 
The International HapMap project (Consortium 2003) has collected information on 
the human genome’s common variation by genotyping individuals from all over the 
world. The HapMap database gathers information on common variation, gene loci, 
haplotypes and tagging SNPs and publishes it in an easy open-access format. The 
goal of the HapMap project is to provide a tool for studying common complex 
disorders, which have been thought to arise from common genetic variation. 
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It is has recently been proven that a large portion of the genetic liability of common 
disorders is caused by rare variation. To enable better mapping of rare variants, the 
1000 Genomes project was initiated in 2008. In addition to SNP variation, the 1000 
Genomes Project will include information on rare and structural variation as well 
with frequency as low as 1 % in the population. The 1000 Genomes Project is 
expected to facilitate recognition of functional variants due to its better coverage of 
the human genome (http://www.1000genomes.org/docs/1000Genomes-
NewsRelease.pdf). 
 
Table 2. Examples on the sequence variation within the human genome. 
Variation Description Example
Single nucleotide 
polymorphism 
(SNP) 
A single nucleotide in a DNA 
sequence is replaced with 
another nucleotide 
CGGATGCTGAC 
CGGACGCTGAC 
Duplication Duplication of a sequence within 
a DNA sequence 
CGGATGCTGAC 
CGGATTGCTGAC 
Insertion, deletion Insertion or deletion of one or 
more nucleotides from a DNA 
sequence 
CGGAT_GCTGAC 
CGGATCGCTGAC 
Microsatellite/ 
minisatellite 
Tandem arrays of repeat units CGGATGCTGAC 
CGGATGCGCGCTGAC 
   
2.2.3.3 Epigenetic variation 
For decades it was believed that variation within the DNA sequence is the only type 
of variation that is heritable. However, new studies have shown that different kinds 
of DNA modifications can be inherited, which alter phenotypes in following 
generations by affecting gene expression. In addition to the genome inherited from 
parents, an individual inherits an epigenome. DNA methylation is one of the best 
studied epigenetic mechanisms. Methylation makes chromatid closed, 
transcriptionally inactive sites. CpG islands are methylation important targets in 
humans. DNA methylation is an important factor in the etiology of Rett’s syndrome, 
mental retardation and fragile X syndrome (Bird 2002, Klose et al. 2006). Along 
with DNA methylation, histone modifications are important epigenetic mechanisms. 
They include various kinds of covalent modifications such as lysine acetylation, 
methylation, SUMOylation, and ubiquitinylation; arginine methylation; serine 
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phosphorylation; and proline isomerization. The different covalent modifications 
have different effects on gene expression for instance, the activation of gene 
expression by acetylation and the repression of gene expression by SUMOylation 
(Roth et al. 2009, Turner 2002, Li et al. 2007a). 
Variation also appears after transcription. For instance, alternative splicing causes 
variation by the numerous splicing combinations of a pre-mRNA molecule. Over   
80 % of human genes are alternatively spliced and the most common splicing 
mechanism is exon skipping (Black 2003, Matlin et al. 2005). 
 
2.3 Genetics of complex disorders 
In the simplest case, a mutation in a gene always causes the same phenotype. 
Disorders caused by single genes are called monogenic or Mendelian disorders. 
They follow a dominant or a recessive model of inheritance. In dominant 
inheritance, a certain variant in a gene causes a phenotype independent of the other 
variant present in the gene pair. In recessive inheritance, a phenotype is expressed 
only if both alleles carry the same variant.  Some important exceptions arise due to 
incomplete penetrance and imprinting. Penetrance is the fraction of the dominant 
genotypes manifesting in given phenotypes in a population. In some cases, recessive 
phenotypes display dominant inheritance pattern. This is due to genetic imprinting, a 
phenomenon where only one of the gene copies is expressed.  Either the paternal or 
the maternal chromosome is silenced, and thus a single mutation in the active gene 
is sufficient to cause a change in phenotype. Monogenic disorders are usually rare. 
The vast majority of common diseases are polygenic or multifactorial (complex) 
disorders. Many genes or genes together with environmental factors contribute to the 
onset of a disorder. An individual might carry several predisposing and protective 
variants in his or her genome and the combination of these variants together with 
environmental factors results in the actual disease phenotype.  
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 a)                                                  b) 
 
Figure 3. The schematic illustrates concepts of a monogenic (a) and a complex 
(b) disorder. In monogenic disorders, a variant (or a few different variants) in a 
single gene causes the disorder phenotype. In complex disorders, both genes 
and environmental factors contribute to the phenotype together. 
 
In complex disorders, the role of the genetic background varies from disorder to 
disorder. Heritability (the proportion of the phenotypic variation attributable to 
genetic variation) of a complex disorder can be estimated based on twin, adoption 
and family studies. The most common way of estimating the proportion of 
inheritance is to study monozygotic and dizygotic twin pairs. The heritability h2 
(narrow sense heritability) can be expressed as the difference in concordance 
between monozygotic and dizygotic twins: 
ℎଶ = {(𝑚𝑧 𝑐𝑜𝑛𝑐𝑜𝑟𝑑𝑎𝑛𝑐𝑒) −  (𝑑𝑧 𝑐𝑜𝑛𝑐𝑜𝑟𝑑𝑎𝑛𝑐𝑒)} ∗ 2 
This gives an estimate for the upper limit of heritability.  
The variation of a DNA sequence is usually studied by genotyping markers 
throughout the region of interest and analyzing them using linkage or association 
methods. The following introduces the main methods and study designs for complex 
disorders. 
2.3.1 Linkage studies 
Linkage is a measure of whether the transmission of certain genetic markers occurs 
together or not. During meiosis, recombination between chromosome pairs might 
occur. The further away from each other two chromosomal loci are, the more likely 
it is that recombination occurs. The recombination fraction which is the probability 
that a gamete produced by a parent is a recombinant is a measure of genetic linkage. 
For loci that are located on different chromosomes the recombination fraction (θ, 
theta) is 0.5. If two loci are located just next to each other on a chromosome, it is 
unlikely that recombination occurs and the recombination fraction is 0. Thus the 
recombination fraction has values 0 ≤ θ ≤ 0.5. 
In genetic studies, it is often impossible to count recombination fractions for each 
individual in each pedigree. Usually, an overall likelihood for a family is calculated 
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the alternative assumptions being θ = 0 (two loci are linked) and θ = 0.5 (two loci 
are not linked). This is the odds of linkage. The logarithmic value of this score gives 
the logarithm of odds known as the LOD score. In a sample including numerous 
families, LOD scores are added up together across the families (Strachan et al. 
2004). 
𝑍(𝜃) = 𝑙𝑜𝑔ଵ଴
𝐿(𝜃)
𝐿(𝜃 = 0.5) 
Usually a LOD score of ≥ 3.3 is considered as the limit for statistical significance 
and corresponds to the significance level of 0.05 (Lander et al. 1995). When 
studying a disease phenotype, the co-segregation of a disease with a certain genetic 
locus is studied in the same manner as when studying two genetic loci. In linkage 
studies, microsatellite markers are usually studied. They can be used for both  
genome-wide linkage studies and the denser fine mapping of certain chromosomal 
regions. 
Since linkage refers to the transmission of studied alleles within families, linkage 
analyses can only be performed within family samples with both offspring and 
parental genotypes available. 
 
a)                           b) 
 
 
Figure 4. Simplified models of the concepts of linkage (a) and association (b). 
Linkage means that a certain variant is inherited in a family together with a 
disease. Therefore, the affected individuals (filled symbols) share a common 
genetic variant. Association is simply a correlation between two studied 
measures  like a genetic variant and a disorder, for example. However, 
association can also be detected within families (a) when the same allele of the 
variant associated with the disorder. 
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2.3.2 Association studies and linkage disequilibrium 
Association analysis is a statistical method that tests if certain alleles occur together 
with a given disease or phenotype. While linkage analyses can only be performed in 
families, analyses of association can be performed in all kinds of samples. Both 
dichotomous and quantitative phenotypes can be studied.  
In case control studies, a simple chi squared test can be performed to test for 
association between genetic markers and the disease phenotype. If the phenotype is 
a continuous quantitative trait, such as height and weight, regression models can be 
used to testing for association. The matching of the cases and controls is critical in 
genetic studies. Poorly matched controls can result in false results (Balding 2006). 
In family studies, if at least one parent is genotyped, a transmission disequilibrium 
test (TDT) can be used. It compares the transmission of alleles from parents to 
affected offspring. The TDT test can be performed both for dichotomous and 
quantitative traits. 
Usually, the genetic variation studied in association analyses are SNPs. Since the 
human genome includes over 14 000 000 SNPs according to current estimates 
(NCBI dbSNP build 131, validated SNPs, http://www.ncbi.nlm.nih.gov/projects/ 
SNP), every 200th nucleotide is polymorphic, and thus testing all the markers within 
a region of interest would be unreasonable. However, not all SNPs are independent. 
If no recombination occurs, neighboring SNPs are inherited as a block called a 
haplotype. The non random association of alleles is called linkage disequilibrium 
(LD). LD can be observed within chromosomes and between different chromosomes 
(Mueller 2004). 
LD in a population can be observed as block like structures (LD or haplotype 
blocks) throughout the genome that are flanked by regions of high recombination 
frequency (International HapMap Consortium et al. 2007). Due to recombination, 
haplotype blocks become shorter with every generation. A majority of haplotypes 
within LD blocks are shared within populations and these common haplotypes 
account for the vast majority of the genome (Jakobsson et al. 2008). By selecting 
and genotyping a single SNP, information on the other SNPs within the same 
haplotype block is captured simultaneously. SNPs that describe a haplotype’s 
variation are referred to as tagging SNPs (tag SNP / htSNP). 
LD can be measured using several methods. The most frequently used pair-wise 
measures of LD are the D prime measure of LD (D’) and the squared correlation 
coefficient (r2). The measures of r2 and D’ are used for different purposes. D’ is a 
useful tool for estimating the probability of historical recombination and for 
recognizing ancestral variants in a given population. The measure of r2 is useful in 
association studies (Balding 2006, Mueller 2004).  
The D’ measure of LD is advantageous for haplotype block estimation and 
construction. Many approaches to the estimation of D’ based LD block structures 
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within family data have been suggested, including the D’ confidence interval and the 
solid spine of LD (Gabriel et al. 2002, Barrett et al. 2005).  The haplotype structure 
can also be estimated using a four-gamete test-based application (Wang et al. 2002). 
In association analyses and linkage disequilibrium tests, haplotypes can be more 
informative than genotypes of single markers (Balding 2006, Gao et al. 2009, Akey 
et al. 2001). Since, variation in the population is structured into haplotypes which 
are inherited as blocks it is reasonable to study these blocks instead of studying 
single SNPs (Clark 2004). Haplotypes lead to analysis with fewer degrees of 
freedom but on the other hand this advantage is minimized if only the tagging SNPs 
are included in the analyses (Balding 2006, Clark 2004). Further, haplotypes are 
suggested being able to capture the combined effects of tightly linked cis-acting 
causal variants (Balding 2006, Clark 2004). 
Both r2 and D’ measures can be utilized for the selection of tag SNPs. In general 
SNPs with LD of D’ ≥ 0.8 or r2 ≥ 0.8 are considered to tag each other with 
sufficiently high accuracy, especially if family (trio) data is available. In small 
samples, LD might be overestimated by D’ and underestimated by r2 (Mueller 2004, 
He et al. 2009).  
In the best case scenario, an association analysis identifies a functional, phenotype-
causing variant. The identified variant would cause an amino acid change in a 
protein, and thus change the protein’s function such that it predispose or outright 
causes a disease. In complex disease genetics, this is rarely the outcome of 
association analyses. The main goal in association studies is to discover loci that 
display association with the studied trait and are in linkage disequilibrium with the 
actual trait locus genotype (Figure 5). The associated markers thus tag and capture 
the genetic variation involved in the etiology of a disease or trait (Balding 2006). 
 
 
Figure 5. A schematic model of an association study of a complex disorder. In 
association studies the recognition of actual functional variants is not often 
possible.The main goal is the identification of loci that correlate with the 
measured phenotype, which then suggests that the actual causative variant is in 
LD or is linked with the associating variant. Therefore, the relationship of 
interest is actually the one between the phenotype and a trait locus genotype 
(indicated with a question mark). 
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2.3.2.1 Genome-wide studies 
In genome-wide studies, genetic markers through the whole genome are analyzed. 
These studies are performed using both linkage and association methods. Genome-
wide linkage scans were previously widely used and they have helped identify 
several important disease loci. 
Recently, genome-wide association studies have become a central study design and 
analytical method in human genetics. They enable genotyping and analyzing of a 
large number of SNPs throughout the genome. Genome-wide SNP assays currently 
include up to 1 000 000 markers (Illumina, San Diego, CA, US / Affymetrix, Santa 
Clara, CA, US) . 
2.3.2.2 Candidate gene studies 
Following the candidate gene approach, specific genes are studied based on the 
hypothesis of their involvement in the etiology of a given disorder (Tabor et al. 
2002). The susceptibility loci have often been recognized via genome-wide linkage 
or association studies. Another method for selecting candidate genes is selection 
based on biological evidence or pathway information. If a gene has displayed 
evidence for association with a disorder, it might be of interest to study the genes 
involved in the same pathways or those that have similar functions to the identified 
genes. Similarly, if a protein is hypothesized to be involved in the etiology of a 
disorder, a gene coding for the protein might be a suitable target for a candidate gene 
study (Tabor et al. 2002). Genetic markers are genotyped in coding sequences, 
flanking regions and possibly splice and regulatory sites of candidate genes in order 
to capture variants driving differences in disease prevalence (Balding 2006).  
2.3.2.3 Statistical significance 
In association studies, a generally accepted limit for statistical significance is P < 
0.05 after correction for multiple testing. A P-value below 0.05 leads to the rejection 
of the null hypothesis and approval of the alternative hypothesis. Current 
methodology enables the testing of a large number of genetic variants in large 
samples. Genotyping platforms have allowed for the detection of variants with 
smaller effect sizes by enabling the testing of even larger samples with more 
markers. However, the new techniques have led to false positive results and have 
made multiple testing a reoccurring critical problem. When performing a large 
number of tests, the likelihood for achieving “a significant result” by change 
increases. Therefore, if 100 tests are performed five of these are expected to display 
P-values < 0.05 by chance.    
A rejection of the null hypothesis when it is actually true is type I error (or a false 
positive or α-error) and leads to the false interpretation of a finding as significant. In 
contrast, type II error (a false negative or β-error) refers to the failure to reject the 
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null hypothesis when it is not true. Type II thus refers to the failure to detect a 
significant difference between the disease and its genetic variant even though a 
significant difference exists.  
To avoid type I and II errors, multiple testing must be controlled and corrected for. 
The Bonferroni correction is considered the most conservative way to correct for 
multiple testing. The correction takes into account the total number of the tests 
performed and assumes that all tests are independent. While the Bonferroni 
correction effectively reduces the rate of false positive, it can result in false negative 
results by being overly conservative. In genetic analyses, the analyzed markers or 
the traits are rarely fully independent and thus the assumption of the test is not 
fulfilled (Balding 2006). Nyholt and colleagues proposed a new method in 2004 for 
estimating the number of independent markers and traits in analyses. Instead of 
using the actual number of performed tests in the correction, estimated numbers of 
independent tests are used (Nyholt 2004). 
Empirical P-values can be estimated using a permutation correction. The 
permutations test the likelihood of observing the achieved P-value by chance by 
randomly testing for the association between the genotype and the phenotype. The 
result is dependent on the number of replications performed. Generally, the accuracy 
of the test increases with the number of permutations, which must at least be the 
number of the tests performed (Balding 2006). 
Replication of the original finding in an independent study material is considered 
adequate proof of a true positive result. In the best case scenario, replication with the 
same allele of the same marker and with the exactly same phenotype is performed 
(Burmeister et al. 2008). Interpretation difficulties often arise with negative 
replication results, especially when studying complex traits if the markers studied 
are not exactly the same, the sample sizes are different and the phenotypes are 
estimated differently. These kinds of findings are often not considered sufficient 
enough to disprove a previous positive finding. If the size of the original study 
sample is large enough, replication can already be performed in the original study by 
splitting the sample into explorative and replication study groups.  
Study specific limits for statistical significance can be estimated using simulations 
based on material characteristics (Wilkinson 2009).   
In complex disorders, the effect size of single genetic variant is often small. Not all 
affected individuals carry a certain risk variant and the risk or susceptibility variant 
is often also present in the healthy population. The impact of the variant can only be 
reliably detected in large samples. The power of the study describes the probability 
of successfully detecting an effect of a particular size (Purcell et al. 2003). If β is the 
probability of type II error, then power is 1 – β. Power depends on several factors 
including the magnitude of effect, sample size and required level of statistical 
significance (α) (Purcell et al. 2003). Power calculations can be performed a priori 
to determine the sample size needed for the study to detect variants of certain effect 
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sizes (Berry et al. 1998). Post hoc power calculations may show whether a study 
was underpowered, which can be useful in interpreting negative results (Purcell et 
al. 2003). Post hoc analysis can also be used for determining the smallest detectable 
effect in a particular study sample (Purcell et al. 2003). 
2.3.2.4 Meta-analyses 
In meta-analyses, the results of multiple studies with similar hypothesis are 
combined. Results are reanalyzed by modeling effect sizes dependent on sample size 
in each study and estimating the overall significance using regression models 
(Munafo et al. 2004). The advantage is the increased power attained with larger 
sample size. Meta-analyses also enable the verification of association findings 
across populations. However, meta-analyses are prone to publication bias by 
referring to studies with positive results that are more likely to be published than 
papers with negative results. Furthermore, strong individual signals may overwhelm 
weaker ones in the combined analyses (Normand 1999). A crucial question for any 
meta-analysis is also the degree of heterogeneity that exists between individual 
studies. In meta-analyses, differences in study designs and populations’ genetic 
backgrounds may result in uninformative outcomes (Munafo et al. 2004). In studies 
of psychiatric disorders the phenotyping method is especially critical, because 
studies that define phenotypes differently may not be combinable in meta-analyses.  
Imputation is widely used in concert with meta-analyses. Imputation is used to 
estimate the genotypes of SNPs based on the surrounding SNPs’ genotypes and 
HapMap LD information (Servin et al. 2007). Imputation is particularly useful for 
combining results obtained from different genotyping platforms (Li et al. 2009). 
Therefore, imputation can be a useful tool in conducting meta-analyses across 
studies.   
2.3.3 Population isolates in complex trait mapping 
A population isolate refers to a population that originates from a small number of 
founders, experiences little immigration and expands primarily through population 
growth. As a result, the genetic variation within an isolated population is less than in 
more mixed populations (Norio 2003).  
Population isolates provide many advantages in genetic studies. In the case of a 
monogenic disorder, a single genetic variant might be responsible for all cases in the 
population (a consequence of the genetic bottleneck effect). Therefore, the 
recognition of disease variants in such a setting is easier than in more mixed 
populations. The number of causative variants of complex disorders is suggested to 
be smaller in isolated populations. Further, the recognition of genetic regions 
involved in the etiology of a certain complex trait is facilitated by the high level of 
LD within the population (Kaessmann et al. 2002). However, the recognition of the 
actual disease causing variants of complex disorders may be challenging since the 
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genetic markers showing significant association can be far away from the actual 
disease locus (Kaessmann et al. 2002). It has thus been suggested that populations 
with high LD are ideal for the coarse mapping of disease loci (Kaessmann et al. 
2002). However, the susceptibility variants in an isolated population may differ from 
those in other populations. Therefore, results from an isolate may not reflect the 
underlying genetic etiology of the disease in other populations. 
Several isolated populations have been studied and utilized in the recognition of 
genetic variants underlying diseases. These populations include the Finnish 
population (Peltonen 2000), the Saami (Laan et al. 1997), the Sardinian population 
(Angius et al. 2001), Old Order Amish (McKusick 1973) and Jewish communities 
(Bonne-Tamir et al. 1986). 
The Finnish population has remained isolated until relatively recently and there are 
several internal isolates within Finland. Finland was inhabited approximately 10 000 
years ago. The major groups making up the current Finnish population are the 
eastern and western populations, which inhabited Finland 4000 and 2000 years ago, 
respectively, according archeological findings (Varilo 1999). For a long time, only 
the coastal regions were inhabited in Finland. As late as the 16th century, the eastern 
and northern parts of Finland were inhabited. Genetic drift in these small sub-
populations along with genetic bottle necks, such as the great famine in the years 
1696 - 1698, has greatly affected the Finnish gene pool (Varilo 1999).The Finnish 
population shows decreased genetic diversity and increased LD compared to other 
European and especially African populations (Peltonen 2000, Lander et al. 1994). 
However, some smaller isolated population for example the Saami display even 
more extensive LD than Finns (Kaessmann et al. 2002). Furthermore, even though 
the Finnish population is more homogenous than many other populations, fine-scale 
population substructures can be observed within Finland (Jakkula et al. 2008). 
 
Figure 6. The schematic describes a schizophrenia pedigree from a Finnish 
isolate. All the affected individuals (filled symbols) share common ancestors 
dating back to 1650 (Hovatta et al. 1999). Only the relatives connecting 
individuals in the pedigree are shown. Pedigree figure courtesy of Teppo Varilo. 
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2.4 Genetics of schizophrenia 
The search for the complex genetic component in the background of schizophrenia 
has been ongoing for decades. To date, no unambiguous variants or risk factors have 
been identified. However, many promising candidate genes have been recognized in 
linkage and association studies. All the recognized variants within these genes 
explain only a small proportion of the genetic risk. Furthermore, all these genes 
include several variants that have been reported to either increase or decrease the 
risk of developing schizophrenia. Therefore, there is evidence of significant genetic 
heterogeneity, which is the phenomenon of a large number of genes and gene 
variants contributing to a trait and different variants within the genes resulting in 
similar phenotypes. All these variants and their interactions together may have an 
impact on the etiology of schizophrenia along with contributing environmental 
factors. 
Many of the candidate genes have been recognized using linkage studies. 
Schizophrenia linkage studies have pointed to almost all chromosomal regions, 
which might be evidence of genetic heterogeneity (Sullivan 2005). However, meta-
analyses have detected consistent evidence of linkage on some chromosomal 
regions. Table 3 summarizes results from two genome-wide linkage meta-analyses 
(Lewis et al. 2003, Ng et al. 2009). Promising candidate genes for schizophrenia 
from linkage studies include RGS4 on chromosome 1q23.3, DAOA on chromosome 
13q33.2, NRG1 on chromosome 8p12 and DPTN1 on chromosome 6p22.3 (Schwab 
et al. 2009).  
Association analyses are currently the most commonly used method for studying the 
genetics of schizophrenia and other disorders with a complex genetic background. 
The Schizophrenia Gene (SzGene) database summarizes current evidence from 
schizophrenia association studies. As of February 2010, it has information on 953 
candidate genes, 1593 studies and 267 meta-analyses. Table 4 summarizes the top 
43 candidate genes and regions listed in the SzGene database as of February 2010 
(Allen et al. 2008).  
Large scale genome-wide association studies were expected to recognize potential 
new genetic risk factors and gather more evidence for the previously identified 
suggestive findings. Instead, all genome-wide studies have displayed only 
suggestive evidence for association at many different loci. All the recognized 
variants have displayed only small effect sizes, a result that is in line with previous 
candidate and linkage studies (Porteous 2008).  
Recent studies have suggested that in addition to common variants with small effect 
sizes, a large component of the genetic etiology of schizophrenia might be explained 
by rare variants with small effect sizes. Such variants include copy number variation 
(CNV) and de novo mutations. Rare deletions at chromosomes 1q21.1, 15q13.3, 
15q11.2 and 22q11.2 and rare duplications at chromosomes 16p11.2 and 16p13.1 
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increase the risk for developing schizophrenia(Kirov 2010, McCarthy et al. 2009, 
International Schizophrenia Consortium 2008, Stefansson et al. 2008, Kirov et al. 
2009a, Rujescu et al. 2009, Kirov et al. 2009b, Bassett et al. 2008). These variants 
are collectively found in 3 % of the patients studied, and thus they only explain a 
small proportion of the genetic causes of schizophrenia (Kirov 2010). Large rare 
(>100 kb) CNVs that disrupt genes are signicantly more frequent among 
schizophrenia patients than among healthy controls, and the genes disrupted tend to 
affect neurodevelopmental pathways (International Schizophrenia Consortium 2008, 
Walsh et al. 2008). Furthermore, de novo CNVs are significantly more common in 
sporadic schizophrenia cases than healthy controls (Need et al. 2009, Xu et al. 
2008). 
In a few cases of patients with schizophrenia, large scale chromosomal 
abnormalities have been detected. Schizophrenia candidate genes DISC1 and 
PDE4B were originally recognized at chromosomal translocation break points. 
DISC1 was recognized in the year 2000 on chromosome 1 in a balanced 
translocation between chromosomes 1 and 11 that co-segregated with mental 
illnesses in a large Scottish pedigree (Millar et al. 2000). Likewise, PDE4B was 
recognized at a balanced translocation break point between chromosomes 1 and 16 
in a Scottish family (Millar et al. 2005). 
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Table 3. Linkage meta-analyses in schizophrenia. The table summarizes the 
chromosomal regions displaying nominal evidence for linkage in meta-analyses 
of partly over-lapping genome-wide studies (Ng et al 2009 and Lewis et al 2003). 
The regions displaying P-values < 0.05 are displayed. Results that are 
significant and suggestive at the genome-wide level are indicated. The Study by 
Ng et al included a total of 32 studies with a sub sample of 22 European studies. 
The study by Lewis et al included 20 studies. 
    Genome-wide sign.  
Study Bin Chromosome cM Significant Suggestive Samples 
Ng2009 5.6 5q31.3-35.1 148.9-178.7  + 32 
Ng2009 2.5 2p12-q22.1 117.5-146.9  + 32 
Ng2009 1.6 1p13.3-q23.3 143.1-171.7   32 
Ng2009 2.8 2q33.3-q36.3 205.7-235.1   32 
Ng2009 2.6 2q21.2-q31.1 146.9-176.3   32 
Ng2009 1.4 1p32.2-p31.1 85.8-114.5   32 
Ng2009 5.7 5q35.1-q35.3 178.7-208.5   32 
Ng2009 8.2 8p22-p12 28.1-56.2   32 
Ng2009 10.6 10q26.12-q26.3 145.9-175.0   32 
Ng2009 3.4 3p14.1-q13.32 95.9-127.9  + Eur22 
Ng2009 8.2 8p22-p12 28.1-56.2   Eur22 
Ng2009 2.8 2q33.3-q36.3 205.7-235.1   Eur22 
Ng2009 5.6 5q31.3-35.1 148.9-178.7   Eur22 
Ng2009 16.2 16p13.12-q12.2 33.3-66.7   Eur22 
Ng2009 3.4 18q22.1-qter 95.9-127.9   Eur22 
Ng2009 6.3 6p21.31-p12.1 56.0-84.0   Eur22 
Lewis2003 2.5 2p12-q22.1 101.6–128.4 +  20 
Lewis2003 5.5 5q23.2-q34 131.5–164.2 +  20 
Lewis2003 3.2 3p25.3-p22.1 32.4–63.1 +  20 
Lewis2003 11.5 11q22.3-q24.1 99.0–123.0 +  20 
Lewis2003 6.1 6pter-p22.3 0–32.6 +  20 
Lewis2003 2.6 2q22.1-q23.3 128.4–154.5 +  20 
Lewis2003 1.6 1p13.3-q23.3 142.2–170.8 +  20 
Lewis2003 22.1 22pter-q12.3 0–33.8 +  20 
Lewis2003 8.2 8p22-p21.1 27.4–55.0 +  20 
Lewis2003 6.2 6p22.3-p21.1 32.6–65.1 +  20 
Lewis2003 20.2 20p12.3-p11 21.2–47.5 +  20 
Lewis2003 14.1 14pter-q13.1 0–40.1 +  20 
Lewis2003 16.2 16p13-q12.2 32.1–67.6  + 20 
Lewis2003 18.4 18q22.1-qter 96.5–126.0  + 20 
Lewis2003 10.1 10pter-p14 0–29.2  + 20 
Lewis2003 1.7 1q23.3-q31.1 170.8–201.6  + 20 
Lewis2003 15.3 15q21.3-q26.1 52.3–85.6  + 20 
Lewis2003 6.4 6q15-q23.2 99.0–131.1  + 20 
Lewis2003 17.3 17q21.33-q24.3 63.6–94.0  + 20 
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Table 4. The top 43 candidate genes for schizophrenia based on the 
Schizophrenia Gene database (SzGene) as of Feb 2010. 
Gene Chr SzGene # GA1 BR2 AE3 First reported by Year 
AHI1 6q23 26 ++ ++ n Amann-Zalcenstein 2006 
AKT1 14q32 20 +++ + - Emamian 2004 
APOE 19q13 14 +++ +++ -  Harrington 1995 
C6orf217 6q23 30 ++ - n Amann-Zalcenstein 2006 
CCKAR 4p15 11 ++ + n Tachikawa 2000 
COMT 22q11 37 +++ +++ + Chen 1996 
DAO 12q24 41 +++ +++ + Chumakov 2002 
DAOA 13q33 7 +++ + + Chumakov 2002 
DISC1 1q42 16 +++ +++ + Wilson-Annan 1997 
DRD1 5q35 13 m +++ n Nothen 1993 
DRD2 11q23 19 +++ +++ + Comings 1991 
DRD4 11p15 12 +++ +++ + Catalano 1993 
DTNBP1 6p22 27 +++ + - Straub 2002 
GABRB2 5q34 18 +++ +++ - Lo 2004 
GRIK3 1p34 35 +++ +++ n Begni 2002 
GRIN2B 12p13 39 +++ +++ n Nichiguchi 2000 
GWA 11p14 15 m + n O'Donovan 2008 
GWA 16p13 24 m + n O'Donovan 2008 
GWA 10q26 34 m + n O'Donovan 2008 
HIST1H2BJ 6p22 23 ++ - n Shi 2009 
HP 16q22 36 +++ ++ + Lovegrove 1965 
HTR2A 13q14 8 +++ +++ - Arranz 1995 
IL1B 2q13 42 ++ ++ n Laurent 1997 
MDGA1 6p21 10 ++ + n Kahler 2008 
MTHFR 1p36 28 +++ + n Arinami 1997 
NOTCH4 6p21 3 +++ + n Wei 2000 
NRG1 8p12 33 +++ +++ + Stefansson 2002 
NRGN 11q24 2 ++  +++ +/- Ruano 2006 
OPCML 11q25 38 + - n O'Donovan 2008 
PDE4B 1p31 4 +++ +++ +/ - Pickard 2007 
PGBD1 6p22 1 + - n Stefansson 2009 
PLXNA2 1q32 17 ++ +++ n Mah 2006 
PPP3CC 8p21 40 + +++ - Gerber 2003 
PRSS16 6p22 22 + - n Stefansson 2009 
RELN 7q22 9 ++ +++ - Akahane 2002 
RGS4 1q23 31 +++ ++ - Chowdari 2002 
RPGRIP1L 16q1 32 + ++ n O'Donovan 2008 
RPP21 6p21 29 + - n ISC 2009 
SLC18A1 8p21 43 ++ ++ n Bly 2005 
 
 
 
   
 
  
Table continues 
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Gene Chr SzGene # GA1 BR2 AE3 First reported by Year 
SRR 17p13 21 ++ ++ - Yamada                           2005 
TCF4 18q21 5 + - n Vincent 1999 
TPH1 11p15 6 +++ +++ n  Paik 2000 
ZNF804A 2q32 25 + - + O'Donovan 2008 
 1 Association studies, evidence from meta-analyses only: m, 1 positive report: +, 2-3 
positive reports:  ++, >3 positive reports: +++ 
2  Biological relevance, no evidence: -, weak: +, some: ++, strong+++ 
3 Expression studies: n: not reported, +: up regulation, -: down regulation, +/-: both up 
and dowm regulation reported   
 
 
2.5 The DISC1 pathway in the genetic etiology 
of schizophrenia 
Disrupted in Schizophrenia 1 (DISC1) is one of the most promising candidate genes 
for schizophrenia with abundant supporting evidence from association, linkage and 
expression studies and animal models. In addition to DISC1 itself, a number of 
genes encoding proteins that interact with DISC1 have emerged as promising 
candidate genes for schizophrenia and other major mental illnesses. As a result, the 
concept of the DISC1 pathway has been proposed. The hypothesis proposes that in 
addition to the disruption of DISC1, the disruption of the pathways DISC1 is 
involved in increases the risk of mental illness (Millar et al. 2003).  
2.5.1 DISC1 
DISC1 was identified as disrupted by a balanced translocation [t(1; 
11)(q42.1;q14.3)] in a large Scottish family with a high prevalence of schizophrenia, 
bipolar disorder and recurrent major depression. The translocation segregated with 
all the previously mentioned mental disorders. Within these families 29 out of total 
of 87 family members carried the translocation. Of these 29 individuals, 18 were 
affected with schizophrenia, bipolar disorder or major depression (St Clair, D. M., 
Blackwood, D., Muir, W., Carothers, A., Walker, M., Spowart, G., Gosden, C., 
Evans,H.J. 1990, Blackwood et al. 2001). 
2.5.1.1 Association and linkage studies 
Independent evidence for DISC1 was found within Finnish cohorts. Initially a strong 
linkage replication was found at 1q42 with intragenic DISC1 markers (Ekelund et al. 
2000, Ekelund et al. 2001). This locus was further studied in Finnish families 
ascertained for schizophrenia and an association between allelic haplotypes of 
DISC1 and schizophrenia was found (Hennah et al. 2003, Ekelund et al. 2004). The 
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strongest association was observed between an allelic haplotype of SNPs rs751229 
and rs3738401, later named HEP3, and the disorder. This haplotype especially 
associated with the disorder in males. Since, many studies worldwide have reported 
an association between DISC1 and schizophrenia (Hennah et al. 2003, Hennah et al. 
2009b, Hodgkinson et al. 2004, Qu et al. 2007, Chen et al. 2006, Chen et al. 2007, 
Kim et al. 2008, Mata et al. 2009, Nicodemus et al. 2007, Rastogi et al. 2009, Saetre 
et al. 2008, Schumacher et al. 2009, Song et al. 2008, Szeszko et al. 2008, Thomson 
et al. 2005a, Wood et al. 2007, Zhang et al. 2006, Hashimoto et al. 2006, 
Kockelkorn et al. 2004, Zhang et al. 2005). However, these studies have mostly 
reported different loci associating with the disorder, and thus no single variant has 
been found (Figure 7). The effect sizes of the studies have been modest, which is to 
be expected when studying complex traits. Despite strong evidence for association 
between DISC1 and schizophrenia, some studies have failed to detect association 
between DISC1 and schizophrenia (Kim et al. 2008, Zhang et al. 2005, Sanders et al. 
2008, Devon et al. 2001, Fallin et al. 2005). 
In addition to the strong evidence for DISC1 in association studies, variants in 
DISC1 have displayed evidence for association with schizophrenia related 
endophenotypes. In Finnish families, DISC1’s HEP3 haplotype associates with 
visual working memory among males (Hennah et al. 2005). Other variants in DISC1 
have displayed association with: the P300 event related potential (Blackwood et al. 
2001), cognitive aging (Thomson et al. 2005a), attention (Liu et al. 2006) and 
sociability (Li et al. 2007b). In the general population, DISC1 has displayed 
evidence of association with anhedonia psychosis proneness measures (Tomppo et 
al. 2009b). DISC1 seems to have an impact on brain physiology by associating with 
reduced gray matter volume in several brain regions, especially in the dorsolateral 
prefrontal cortex (Cannon et al. 2005). It also affects hippocampal structure and 
function (Callicott et al. 2005). 
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Figure 7. The schematic describes the associated loci within the DISC1-TSNAX 
region to date. Only association studies of schizophrenia have been included. 
 
DISC1 seems to be involved in the etiology of other major mental illnesses as well 
as some other neurodevelopmental disorders. Associations of DISC1 with both 
bipolar disorder and schizoaffective disorder were reported in the Scottish 
population in the year 2005 (Thomson et al. 2005b). In 2006, an association between 
DISC1 and major depression was reported (Hashimoto et al. 2006). DISC1 displays 
evidence for association with autism and Asperger’s syndrome in Finnish families 
(Kilpinen et al. 2008). Just recently, associations between DISC1 and anxiety (Harris 
et al. 2010) and chronic fatigue syndrome (Fukuda et al. 2010) have been reported.  
2.5.1.2 DISC1 protein structure 
The alternative DISC1 transcripts give rise to four predicted protein isoforms in 
humans. The full-length protein isoform comprises 845 amino-acid residues (~100 
kDA) . The full-length human DISC1 protein is predicted to consist of an N-terminal 
region, often referred to as the globular ‘head’ domain (encoded by exons 1 and 2) 
and an alpha-helical coiled–coil-containing C-terminal region (encoded by exons 3–
13)(Millar et al. 2000, Millar et al. 2001). The experimental three-dimensional 
structure and biophysical characterization of the encoded protein is still lacking 
(Chubb et al. 2008). 
  
 
THL – Research 37 49  The DISC1 Pathway in the  
Genetic Etiology of Schizophrenia 
2.5.1.3 Expression 
DISC1 is expressed in many tissues around the human body including the central 
nervous system, heart, placenta, kidneys and pancreas (Millar et al. 2000, James et 
al. 2004). The expression levels of DISC1 vary greatly throughout development. 
Disc1 is actively expressed throughout mouse brain development in neuronal cells.  
It is expressed at a high level in the hippocampus and transiently in thalamus (Austin 
et al. 2004). The expression of the Disc1 100kDa isoform is the most active during 
the embryonic day 13.5 and the postnatal day 35. The days correspond to the time 
points of active neurogenesis and onset of puberty in human development (Schurov 
et al. 2004). Recently, Mao and colleagues reported that Disc1 is also highly 
expressed in the embryonic ventricular/subventricular zones of the cortex where 
neural progenitor cells reside (Mao et al. 2009, Brandon et al. 2009). The knock-
down of Disc1 on embryonic day 13 leads to decreased neural progenitor cell 
proliferation and premature neuronal differentiation in the developing cortex 
(Kamiya et al. 2005). 
In human adult brain tissue (post mortem), DISC1 is expressed in the dentate gyrus 
in the hippocampus and temporal and parahippocampal cortex (James et al. 2004, 
Lipska et al. 2006, Miyoshi et al. 2003). In studies using mice and monkeys, DISC1 
is expressed widely in the cerebellum, cerebral cortex, ammon’s horn, olfactory 
bulbs, paraventricluar and arcuate nuclei, and amygdala (Schurov et al. 2004, 
Miyoshi et al. 2003, Ozeki et al. 2003, Austin et al. 2003, Ma et al. 2002).  
Expression in the hippocampus is apparent in all species studied (Harrison 2004).  
In immature and proliferating neurons, cells DISC1 is expressed in the centrosomes, 
mitochondria and nuclei of cell bodies. In the nucleus, DISC1 interacts with the 
dynein motor complex and ATF4/PML transcriptional machinery (Chubb et al. 
2008, Jaaro-Peled et al. 2009). In mature neurons DISC1 is mainly found in the 
nucleus and the post synaptic density.  In the latter it interacts with PDE4B and is 
suggested to be involved in the regulation of synaptic plasticity (Camargo et al. 
2007) (Jaaro-Peled et al. 2009). DISC1 is also expressed in neurites (Chubb et al. 
2008). Within hippocampal neurons, DISC1 is expressed within growth cones 
(Chubb et al. 2008).  
It has been suggested that since DISC1 localizes in multiple cell compartments and 
interacts with different proteins at different locations, it might have different roles in 
different cell compartments. Furthermore, different DISC1 isoforms might interact 
with different proteins as a result of preferential localization in a particular sub-
cellular compartment (Chubb et al. 2008).  
2.5.1.4 Disc1 mouse models 
Developing mouse models for psychiatric disorders is difficult, because phenotypic 
assessment is challenging and the disorders are heterogeneous in etiology and 
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patophysiology. Some key features of schizophrenia such as hallucinations might be 
human-specific. Even though no schizophrenic mouse exists, several schizophrenia-
related symptoms and behaviors can be studied in mice. Such phenotypes include 
hyperresponsitivity to novelty, hypersensitivity to psychostimulants and working 
memory deficits (Desbonnet et al. 2009). Several anatomical and physiological 
features can also be studied (Desbonnet et al. 2009). 
Numerous Disc1 knockout and transgenic mice have been studied to date. Mice of 
the 129S9 Sv/Ev strain have been shown to carry a deletion polymorphism in exon 6 
of Disc1. The deletion introduces a termination codon in exon 7 stopping full-length 
Disc1 production. The mice display working memory deficits (Koike et al. 2006). 
Disc1 mice with chemical mutagenesis (ENU, ethyl nitrosurea alkylation) on exon 
express impairment in prepulse inhibition and latent inhibition with enhanced 
locomotor responsitivity to novelty (Clapcote et al. 2007). Transgenic mice 
expressing a dominant-negative form of Disc1 have enlarged lateral ventricles and 
enhanced locomotor responsitivity (Hikida et al. 2007). Working memory deficits 
have also been reported in mice with inducible expression of the Disc1 C-terminal 
fragment in the early postnatal period (Li et al. 2007b). 
2.5.2 The DISC1 pathway 
DISC1 is a multifunctional anchoring molecule that regulates interacting proteins in 
different subcellular compartments (Chubb et al. 2008, Jaaro-Peled et al. 2009, 
Ishizuka et al. 2006). A large number of proteins that bind to the DISC1 protein 
have been recognized through protein complex (co-) immunoprecipitation and yeast 
two-hybridization (Millar et al. 2005, Millar et al. 2003, Miyoshi et al. 2003, Ozeki 
et al. 2003, Camargo et al. 2007, Miyoshi et al. 2004, Morris et al. 2003, Brandon et 
al. 2004, Taya et al. 2007, Shinoda et al. 2007). Ingenuity Pathway Analysis Tool 
reports 135 proteins that directly interact with the DISC1 protein (Feb 2010, 
http://www.ingenuity.com/). DISC1 and the binding proteins are mainly involved in 
functions related to the cytoskeleton, cell cycle, signal transduction, intracellular 
transport / exocytosis, Golgi and central nervous system development (Chubb et al. 
2008). Table 5 summarizes the DISC1 pathway genes that have been studied for 
association with schizophrenia. The following section describes the functions of the 
key DISC1 binding partners and how they are thought to contribute to the etiology 
of schizophrenia. 
PDE4B was first connected with schizophrenia when found to be disrupted by a 
balanced translocation between chromosomes 1 and 16 in a Scottish pedigree. This 
translocation segregated with schizophrenia (Millar et al. 2005). Since then, several 
reports have implicated associations between PDE4B and schizophrenia (Millar et 
al. 2005, Pickard et al. 2007, Fatemi et al. 2008a, Numata et al. 2008, Kahler et al. 
2010, Tomppo et al. 2009a). PDE4B belongs to a large protein family with other 
PDE4s (PDE4A-PDE4D). Human PDE4B expresses three isoforms. The protein 
binds to DISC1 in a cAMP dependent manner and catalyzes cAMP. PDE4B is a 
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target of prototypical antidepressant rolipram, which inhibits its cAMP catalyzing 
activity (Houslay et al. 2003). Mice deficient in Pde4b or Pde4d behave as if they 
were treated with antidepressants by having reduced motility in a forced swimming 
task (Houslay et al. 2003). PDE4s are homologous to the Drosophila Melanogaster’s 
learning and memory gene Dunce. Mutations in this gene cause learning and 
memory deficits (Davis 1996). Moreover, Dunce mutants have altered axonal 
growth cone motility, neuronal function and synaptic plasticity (Kim et al. 1996, 
Delgado et al. 1998, Lee et al. 2000).  
The homologous NDE1 and NDEL1 are candidates for schizophrenia due to their 
involvement in neuronal migration and neuronal outgrowth and binding to DISC1 
((Hayashi et al. 2005, Sasaki et al. 2005)). Expression levels of NDEL1 are reduced 
in brain tissue among individuals with schizophrenia (Lipska et al. 2006). 
Previously, NDE1 and NDEL1 were linked to early age neuronal development in 
mice (Brandon et al. 2004, Sasaki et al. 2005, Schaar 2004). However, recent 
findings support a wider role for NDEL1 in adult neurogenesis in mice along with 
DISC1 (Duan et al. 2007). Both NDE1 and NDEL1 have been implicated in the 
etiology of schizophrenia in association studies (Tomppo et al. 2009a, Hennah et al. 
2007, Burdick et al. 2008). 
NDE1 and NDEL1 interact with DISC1 and another DISC1 binding partner LIS1 
(Brandon et al. 2004). Disruption of LIS1 may lead to lissencephaly, a difficult 
neurodevelopmental condition marked by severe brain malformation (Kato et al. 
2003, Cardoso et al. 2000, Lo Nigro et al. 1997).  Mutations in one copy of the 
PAFAH1B1 (LIS1) gene cause deficits in cortical layering, neuronal migration and 
neuroblast proliferation in mice (Hirotsune et al. 1998, Gambello et al. 2003). 
Deficits in one copy of Pafah1b1 also result in aberrant neurogenesis in adult mice 
hippocampus (Wang et al. 2007). Therefore, this gene is also involved in neuronal 
development. Expression levels of LIS1 are reduced among schizophrenia patient 
(Lipska et al. 2006). 
GSK3β has been implicated in the proliferation of embryonic and adult neural 
progenitor cells through the GSK3β/β-catenin pathway. In neuronal progenitor cells, 
DICS1 interacts directly with GSK3β, which reduces the phosphorylation of β-
catenin and increases its stability. Consequently, the Wnt signaling pathway is 
activated (Jaaro-Peled et al. 2009, Mao et al. 2009). Two studies have reported 
association between GSK3β and schizophrenia (Souza et al. 2008, Scassellati et al. 
2004). Interestingly, GSK3β activity is affected by many antipsychotic drugs and 
lithium (a mood stabilizer). Beaulieu and colleagues have implicated GSK3β in 
serotonin homeostasis and suggested that GSK3β signaling is an important pathway 
through which serotonin deficiency causes abnormal behavior (Ming et al. 2009, 
Beaulieu et al. 2008). 
FEZ1 associated with the disorder in the Japanese population but attempts to 
replicate this finding have not succeeded (Yamada et al. 2004, Koga et al. 2007, 
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Hodgkinson et al. 2007). However, expression and mouse studies support the 
involvement of FEZ1 in the etiology of schizophrenia. Reduced Fez1 expression in 
rat hippocampal neurons results in neuronal deficits, such as defects in axonal 
outgrowth. (Rastogi et al. 2009, Koga et al. 2007, Hodgkinson et al. 2007). 
Interaction between DBZ and DISC1 has also been suggested to be involved in 
neuronal outgrowth (Hattori et al. 2007).  However, no evidence of association for 
the involvement of this gene in the etiology of schizophrenia has been reported to 
date (Chubb et al. 2008, Jaaro-Peled et al. 2009). 
ATF4 and ATF5, which interact with nuclear DISC1, are key regulators of the stress 
response in neurons. Thus, together with DISC1 they are hypothesized to play roles 
in the response to environmental factors relevant to schizophrenia, such as birth 
hypoxia and congenital infections (Jaaro-Peled et al. 2009). Qu and colleagues have 
reported association between ATF4 variants and schizophrenia, but additional 
evidence for this gene is still lacking (Qu et al. 2008). Positive association findings 
have been also reported for PCNT (Numata et al. 2009a, Anitha et al. 2009). 
A number of DISC1 binding partners have been along with DISC1 implicated also 
in other major mental illnesses and in autism (Braun et al. 2007, Kahler et al. 2010, 
Numata et al. 2009a, Shifman et al. 2008, Heck et al. 2008, Calboli et al. 2010, 
Numata et al. 2009b). This implies that these disorders might share a common 
etiologic component such as neuronal development (Chubb et al. 2008, Brandon et 
al. 2009).   
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Table 5. The table summarizes the DISC1 binding partners that have been 
studied for their involvement in the genetic liability for schizophrenia. For the 
genes displaying positive evidence for involvement in the etiology of 
schizophrenia, the first publication is implicated. 
 Evidence for involvement if the etiology of schizophrenia Other mental 
illnesses Gene GA AE AM Other Reported
ATF4 + n n Qu 2008
ATF5 n n n
CIT n n n
DBZ n n n
DISC1 +++ + + Translocation, 
linkage 
Millar 2000 BPD AD MD ANX 
SZ-A SZ-S CFS 
DPYSL2 ++ n n Nataka 2003
FEZ1 + - + Yamada 2004
GRB2 n n n
GSK3B ++ n n Souza 2008
KIF5A n n n
LIS1 n + + Lipska 2006
MAP1A n n n
MIPT3 n n +
MPPED1 n n n
NDE1 + n n CNV, linkage Hennah 2007
NDEL1 ++ + n Burdick 2008
PCNT ++ n n Numata 2009
PDE4B +++ + + Translocation Millar 2005 MD AD 
PDE4D + n n Tomppo 2009 ANX 
SPARCL1 + n n Kähler 2008
SPTAN1 n n n
TSNAX ++ n n
TUBA1A n n n
YWHAE + - n Ikeda 2008
YWHAG n n n
YWHAZ + n n Jia 2004
ZNF365 n n n
GA: genetic association, n: not reported, +: 1 positive report, ++: 2-3 positive reports, 
+++: >3 positive reports 
AE: altered expression: n: not reported, +: up regulated, -: down regulated,  
AM: animal models: n: not reported, +: animal model reported 
BPD: bipolar disorder, AD: autism spectrum disorders, ANX: anxiety, SZ-A: 
schizoaffective disorder, SZ-S: schizophrenia spectrum disorders, MD: major 
depression, CFS: chronic fatigue syndrome 
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3 Aims of the study 
The aim of the present study was to study the role of the DISC1 pathway in the 
genetic backgrounds of schizophrenia and related traits in the Finnish population.  
The DISC1 pathway refers to the DISC1 gene and the other genes encoding proteins 
that interact with DISC1.  
The following specific aims were addressed in the study: 
 In Study I, the aim was to recognize new schizophrenia susceptibility loci 
by utilizing schizophrenia genome-wide linkage data and conditioning it by 
DISC1 risk variants previously recognized in the same sample. A follow up 
was also carried out by mapping the association of the recognized loci with 
schizophrenia and endophenotypes for schizophrenia. 
 In Study II, the aim was to study 11 additional DISC1 pathway genes for 
association with schizophrenia and endophenotypes of schizophrenia.  
 Study III aimed to replicate a previously reported interplay between variants 
in DISC1 and to study the impact of DISC1 on psychosis proneness in the 
general, healthy population. 
 In Study IV, the aim was to recognize new schizophrenia susceptibility loci 
by using psychosis proneness measures, genome-wide SNP data and a 
DISC1-conditioned approach based on the findings from Study III. 
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4 Materials and methods 
4.1 Table of methods used 
A description of the methods used in this study can be found in the original 
publications accompanying this thesis, as described in Table 6. 
Table 6. Table of the methods used. 
Material or Method Original  Publication 
Study sample  
Finnish Schizophrenia Family Sample I, II 
Quantitative trait sub-sample I, II 
Control Sample I, II 
Northern Finland Birth Cohort 1966 (NFBC66) III, IV 
Phenotype Methods  
DSM-IV Concensus Diagnosis I, II 
Quantitative Neurocognitive Traits I, II 
Psychosis Proneness Scales III, IV 
Statistical Methods  
SNP Selection I, II, III 
Genotype Quality Controls I, II, III, IV 
SNP Association I, II, III, IV 
Haplotype Association I, II 
Bonferroni Correction III 
Replication II 
Permutations I, II, IV 
Haplotype construction I, II 
Quantitative Trait Association I, II, III, IV 
Candidate Genes I, II, III 
Genome-wide Association IV 
Genome-wide Linkage I 
Laboratory Methods  
Genotyping I, II, III, IV 
Sequenom I, II, III 
Taqman III 
Illumina IV 
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4.2 Study samples 
4.2.1 Finnish schizophrenia family sample 
The Finnish schizophrenia family sample is a large sample collection used in many 
studies of schizophrenia in the Finnish population. Among other studies, this same 
sample has been previously used in genome-wide linkage and association studies of 
schizophrenia (Hennah et al. 2003, Ekelund et al. 2000, Ekelund et al. 2001, 
Ekelund et al. 2004, Tomppo et al. 2009a, Hennah et al. 2007, Wedenoja et al. 2007, 
Paunio et al. 2001, Hovatta et al. 1994, Hovatta et al. 1998, Hovatta et al. 1999, 
Turunen et al. 2007, Pietilainen et al. 2009). This family sample has been used in 
Studies I and II. In Study I the whole sample was analyzed at once (476 families). In 
the Study II, the family sample was randomly split into two non-overlapping sub-
samples to be analyzed as exploratory (171 families) and replication data sets (305 
families). 
The collection of families was started in 1988 by the National Public Health Institute 
(since 2009 the National Institute for Health and Welfare) and the sample collection 
method has not changed in the years since. The individuals with schizophrenia 
(probands) are identified from three nationwide data registers of: the hospital 
discharge, disability pension, and reimbursed medication (Lichtermann et al. 1998). 
The first-degree family members of each proband were thereafter identified through 
the Population Register Centre, enabling the construction of pedigrees. Personal data 
recorded in the Population Information System are maintained by the Population 
Register Centre, and local register offices record personal identity codes, family 
relations and date of birth and death (if applicable). The registers have allowed for 
the identification of 33,371 individuals born 1940-1976 who have been diagnosed 
with schizophrenia (according to the ICD-8, DSM-III-R, or ICD-10 classifications) 
in the years 1969-1998 (Lichtermann et al. 1998). Family information has been 
collected from the Finnish population register and pedigrees have been constructed. 
The sample now includes 476 nuclear families with a total of 2756 individuals, of 
which 1857 have been genotyped. The lifetime diagnosis for each case in the study 
sample has been evaluated according to DSM-IV criteria independently by two 
psychiatrists (American Psychiatric Association, Diagnostic and Statistcal Manual 
of Mental Disorders, 1994). Concordance between the two psychiatrists is high 
(kappa values range from 95% to 99%, depending on the liability class). In the case 
of a discrepancy, a third psychiatrist assessed lifetime diagnosis, and the consensus 
best-estimate lifetime diagnosis was made. A schematic of the collection is given in 
Figure 8. 
In addition to the schizophrenia proband, family members with other psychiatric 
illnesses were also identified. It was therefore possible to define affection status with 
increasingly inclusive liability classes (LC). The LC1 consists of individuals 
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diagnosed with schizophrenia (N = 651). LC2 adds individuals diagnosed with 
schizoaffective disorder to the sample (N = 132); LC3 individuals affected with 
schizophrenia spectrum disorders (schizoid, schizotypal and paranoid personality 
disorders, schizophreniform, delusional and brief psychotic disorder, and psychosis 
not otherwise specified (N = 103); and LC4 individuals with bipolar affective 
disorder or major depression with and without the presence of psychosis (N = 83). In 
Study I, the widest definition of affection status (LC4) was used in order to include 
all possible information afforded by the sample. In Study II, we restricted our end-
state diagnosis phenotype to LC3 due to increasing evidence of genetic liability: 
among families ascertained for schizophrenia the genetic liability for disorders in 
both LC2 and LC3 is increased (Tienari et al. 2003), whereas the disorders in LC4—
despite having some overlap in genetic risk—display similar genetic liability as the 
general population (Tienari et al. 2003, Blackwood et al. 2007, Shifman et al. 2004).  
 
 
Figure 8. Schizophrenia family sample collection. 
 
4.2.2 Neurocognitive quantitative trait sub-sample 
For a sub-sample of 186 families (746 individuals), a neuropsychological test battery 
was administered (Tuulio-Henriksson et al. 2002). The tests were administered in a 
fixed order by experienced psychologists and specially trained psychiatric nurses.  
The test scoring was performed by experienced psychologists. The following 
variables were used in the analyses.  
First, from the Wechsler Memory Scale—Revised (WMS-R) (Wechsler 1987) we 
included Verbal and Visual Span forward subtests as measures of auditory and 
  
 
THL – Research 37 58  The DISC1 Pathway in the  
Genetic Etiology of Schizophrenia 
visual attention, respectively (Study II). The respective backward condition of these 
WMS-R subtests was used as measures of verbal (Study II) and visual working 
memory (Studies I and II). Second, from the California Verbal Learning Test 
(CVLT) (Delis, D.C., Kramer, J.H., Kaplan, E. and Ober,B.A. 1987), total recall 
from trials 1–5 were used as a measure of learning (Study II). The other included 
CVLT variables were semantic clustering as a measure of learning strategy and 
short-delay and long-delay recall (Study II). Third, from the Wechsler Adult 
Intelligence Scale—Revised (WAIS-R)(Wechsler 1981), the Vocabulary subtest was 
included as an estimate of basic ability, and the Digit Symbol subtest was included 
as a measure of information processing speed (Study II). The selected traits are 
either direct measures of learning and memory—such as short-delay memory, long-
delay memory, and verbal learning—or highly relevant to learning process, such as 
auditory attention, visual working memory, verbal working memory, verbal 
attention, and semantic clustering. The test scores were normally distributed in our 
sample.  
4.2.3 Control sample 
The control sample used in studies I and II includes 57 anonymous Finnish families 
that all included three family members: father, mother and their child. No phenotype 
data was available for these families. This sample represents a random sample of the 
Finnish population. In Study I this control sample was used to derive the unbiased 
SNP and haplotype frequencies in the study sample. This sample was also included 
in the SNP and haplotype association analyses in study I and in SNP association 
analyses in Study II in order to maximize the number of unaffected individuals for 
calculations of expected allele frequencies. Parents of these families were used as 
control samples in study II.  
4.2.4 Northern Finland Birth Cohort 1966  
The Northern Finland Birth Cohort 1966 was used in Studies III and IV. The study 
was started in 1965 in the two northernmost provinces in Finland: Oulu and 
Lapland. Data on the individuals born into this cohort and their parents were 
collected from the 24th gestational week. The cohort included 12 055 mothers and 
they had 12 068 deliveries (13 women delivered twice). The cases belonging to the 
survey period were determined by the calculated term. The study population 
comprised 96.3% of all births in 1966 in that area. Altogether, 12 231 children were 
born into the cohort and 12 058 of them were live born (Rantakallio 1969). The 
original cohort data have been supplemented by data collected by postal 
questionnaires at the ages of 1, 14, and 31 years and by various hospital records and 
national register data.  Participants underwent a physical examination at age 31. The 
data analyzed in this study were included in a questionnaire given to individuals at 
the 31-year follow-up. A total of 4651 individuals completed the questionnaire and 
provided a DNA sample and written informed consent; this represented 40.3% of the 
11 541 individuals who could be contacted at age 31 and 77.1% of the 6033 
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individuals who took part in the follow-up study at age 31. Of the 4651 individuals, 
55.7% were female and 44.3% were male (Tomppo et al. 2009b).  
The scales included in Study III were the Perceptual Aberration Scale (PER) 
(Chapman et al. 1978),Revised Social Anhedonia Scale (RSAS) (L. Chapman, PhD, 
unpublished test, 1982) (Chapman et al. 1976), Revised Physical Anhedonia Scale 
(RPAS) (L. Chapman, unpublished test, 1978) (Chapman et al. 1976) and Schizoidia 
Scale (SCHD) by Golden and Meehl (Golden et al. 1979). These scales were 
selected to assess normal properties that correspond to positive and negative aspects 
of psychotic disorders. The scales were translated into Finnish by a native speaker 
and were then professionally back translated into English and corrected (Ekelund et 
al. 1999). The scale items were mixed into a single pen-and-paper questionnaire 
with items from other scales and were tested in a sample of employees from the 
National Public Health Institute.  
In Study IV, we looked for association at the genome-wide level using the RSAS 
and RPAS scales, because they showed association with DISC1 (Tomppo et al. 
2009b). The sample was stratified based on individuals’ DISC1 variant profiles. The 
number of individuals carrying the DISC1 risk and protective variants were 3049 
and 962, respectively. The remaining individuals that did not carry either of these 
variants comprised a neutral group (N = 505). 
The psychometric properties of these scales in this specific setting have been 
previously reported (Miettunen et al. 2004, Miettunen et al. submitted). Recent 
psychometric studies have shown that the dimensions of schizotypy measured by the 
RSAS and RPAS scales are not interchangeable indicators of a single taxon as 
originally proposed by Meehl (Meehl 1962). Instead they represent different 
underlying latent traits, namely perceptual aberration as opposed to social anhedonia 
(Horan et al. 2004). Originally these two scales, but not physical anhedonia, were 
considered valid indicators for future onset of psychotic disorders (Chapman et al. 
1994). Further work on the same longitudinal sample, reviewed by Blanchard et al 
(Blanchard et al. 2000), showed that after controlling for the effects of the other 
psychosis proneness measures social anhedonia independently and most clearly 
predicted later schizophrenia-spectrum personality disorders, social dysfunction, and 
poor quality of relationships. However, in a recent report by Fonseca-Perdrero and 
colleagues both physical anhedonia and social anhedonia were shown to be adequate 
indicators for later schizophrenia spectrum disorders (Fonseca-Pedrero et al. 2009). 
In addition, a recent report by Horan and colleagues (Horan et al. 2008) showed that 
along with Social Anhedonia Scale, Physical Anhedonia Scale can be used as a 
psychosis vulnerability indicator. In that study, patients showed steady elevations on 
the Physical Anhedonia Scale across time and clinical state, consistent with a stable 
vulnerability indicator. 
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Table 7. Descriptive statistics on the outcome measures in the NFBC66 sample.  
  Scores of the combined sample/women/men 
  PER RSAS RPAS SCHD 
N 4651 4651 4651 4651 
Mean 2.33/2.54/2.06 9.39/8.08/11.03 15.02/12.70/17.94 2.54/2.77/2.25 
SD 3.17/3.27/3.03 5.44/4.70/5.84 6.98/5.85/7.20 1.41/1.36/1.40 
Range 0-35 (all) 0-40 (all) 0-61 (all) 0-7 (all) 
Abbreviations: PER, Perceptual Aberration Scale; RPAS, Revised Physical Anhedonia 
Scale; RSAS, Revised Social Anhedonia Scale; SCHD, Schizoidia Scale by Golden and 
Meehl. 
 
Table 8. Descriptive statistics on the outcome measures after the DISC1-based 
stratification in the NFBC66 sample in Study IV. 
  Scores of the combined sample 
Variable RSAS  RPAS 
Model Risk
3049 
Protective
962 
Neutral
505 
 Risk
3049 
Protective 
962 
Neutral 
505 N  
Mean 9.64 8.97 9.52  15.28 14.53 15.04 
SD 5.51 5.51 5.62  7.12 6.95 7.12 
95% CI of   
hhmean 
9.44-
9.84 
8.62- 
9.33 
9.02-
10.03  
15.02-
15.53 
14.08-
14.97 
14.40-
15.68 
Range 0-40  0-61 
Abbreviations: RPAS, Revised Physical Anhedonia Scale; RSAS, Revised Social Anhedonia 
Scale. 
 
 
 
Figure 9. Northern Finland Birth Cohort 1966 sample collection (NFBC66). 
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4.3 Statistical methods 
4.3.1 Linkage analyses 
A genome-wide linkage analysis was performed on two stratified samples (carriers 
of the DISC1 risk haplotype HEP3: 145 families, non-carriers of the DISC1 risk 
haplotype HEP3: 313 families) and the combined data set using genotypes from 443 
microsatellite markers. The microsatellites were previously genotyped and analyzed 
by our research group (Ekelund et al. 2000, Ekelund et al. 2001, Ekelund et al. 2004, 
Paunio et al. 2001, Hovatta et al. 1999). Two-point linkage analysis was carried out 
using the heterogeneity model in the MLINK program (Lathrop et al. 1985). The 
scan was performed in all three samples for all four increasingly inclusive LCs and 
using both dominant and recessive models. Testing all of these models in each 
sample meant that 24 genome scans were being tested. Therefore, simulation of the 
data was essential to derive the significance of any results in the face of multiple 
testing and the additional biasing presented by the conditioning on DISC1. The 
simulation of linkage significance was carried out by randomly reassigning 
genotypes to individuals at frequencies identical to the original analysis, to create 
100 random replicates of the sample. Across all eight models for the three samples 
(un-stratified, HEP+, HEP-), only LOD-scores >3 met the 0.05 level of significance. 
4.3.2 Association analyses 
4.3.2.1 SNP selection 
For the studies of association between the DISC1 pathway genes and schizophrenia 
(Studies I and II), the SNPs were selected from the international HapMap project 
database builds # 15 (study I) and #16, phase 1 (study II) (Consortium 2003). The 
LD structure of candidate genes was defined using all the SNPs with a minor allele 
frequency > 5% in the population of European descent (CEU, Utah residents with 
ancestry from Northern and Western Europe). We used the Haploview program and 
the solid spine of LD method for defining the LD block structure (D’ > 0.8). The 
method searches for a "spine" of strong LD running from one marker to another in 
which the first and last markers in a block are in strong LD with all intermediate 
markers while intermediate markers are not necessarily in LD with each other 
(Barrett et al. 2005). LD blocks with a Hedricks multiallelic D’ ≥ 0.9 were 
combined. The method treats each block as a single marker and estimates the LD 
between the blocks (Hedrick 1987). Haplotype tagging SNPs were selected to obtain 
optimal coverage of the genes. Additional SNPs from the HapMap and Perlegen 
(Hinds et al. 2005) databases were selected to provide coverage if genotypes of 
tagging SNPs were not of sufficiently high quality. 
In study III, the SNPs selection was based on previous study of DISC1 (Hennah et 
al. 2009b). In that study the methodology for SNP selection was the same as 
  
 
THL – Research 37 62  The DISC1 Pathway in the  
Genetic Etiology of Schizophrenia 
described above. Study III included SNPs that best tagged the DISC1 gene and SNPs 
having previously displayed association with schizophrenia.  
In Study IV, the sample was genotyped using the genome-wide Illumina HumanHap 
370K SNP array. 
4.3.2.2 Haplotype estimation 
To perform haplotype analyses in the family sample (Studies I and II), we identified 
haplotype blocks according to the LD structure defined by Haploview, as described 
above. In genes NDE1, NDEL1, TRAF3IP1, ATF4, ATF5, MAP1A, TUBA1A, FEZ1 
and PCNT only one haplotype block for each gene was present. PAFAH1B1, PDE4B 
and PDE4D included 2, 10 and 17 LD blocks, respectively. In ATF4, PDE4B and 
PDE4D we were able to tag 0, 8 and 16 blocks respectively. All the blocks were 
tagged in other genes,.The LD structure in our sample correlated well with the LD 
structure defined using the HapMap CEU population. However, for NDE1 and 
NDEL1 the LD pattern in the CEU population predicted two LD blocks, while only 
one block was predicted according to our sample. We analyzed the blocks as one.  
4.3.2.3 Dichotomous disease phenotype 
SNP association analyses in Studies I and II were performed using the 
Pseudomarker program (Goring et al. 2000). The program performs linkage as well 
as linkage disequilibrium analyses on samples of mixed form (families and trios 
being combined here), corrects for the effect of linkage on the association tests and 
is able to deal with cases where parental genotypes are not known (Goring et al. 
2000). 
Haplotype association analyses were performed in Study I using the TRANSMIT 
program (Clayton 1999). It can test for transmission of a haplotype even when the 
phase is unknown and when parental phenotypes are not complete. The program is 
able to compensate for the presence of linkage when analyzing family data by 
calculating a robust variance estimate and by enabling the testing of one offspring 
per family. However, TRANSMIT does not take controls into account in the 
analyses. 
Haplotype association analyses in study II were performed in a two-stage design 
using the chi squared test to test each possible haplotype within an LD block against 
all other haplotypes in a 2x2 table (affected vs. controls). A global test in a 2 x n 
table was also performed for haplotypes displaying significant association. 
In Study I, results were corrected for multiple testing using permutation and 
Bonferroni corrections. The association tests between affection status and gene 
variants in Study II were performed using the two-stage study design described 
above.  
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4.3.2.4 Quantitative phenotypes 
In Studies I and II, quantitative neurocognitive phenotypes (endophenotypes) of 
schizophrenia were studied. Analyses were performed for the SNPs and haplotypes 
that displayed significant evidence for association with schizophrenia. The measures 
used in Studies III and IV were intermediate phenotypes for psychosis.  
4.3.2.4.1 Quantitative neurocognitive traits 
Analyses were performed using the QTDT program and the orthogonal model 
(Abecasis et al. 2000a, Abecasis et al. 2000b). Haplotypes were re-coded to form 
“bi-allelic” markers, so as to test the hypothesized variant against all others 
combined. Age, sex and affection status according to LC3 (study II) and LC4 (Study 
I) were used as covariates in the analysis. To achieve empirical results, 100 000 
permutation were performed. 
4.3.2.4.2 Psychosis proneness phenotypes 
In Study III, the analyses were performed using SPSS (SPSS, version 15.0 for 
Windows; SPSS Inc, Chicago, Illinois). Because all test variables were slightly 
skewed to the right, logarithmic transformations were performed for each variable. 
After transformation, the RSAS, RPAS and SCHD were normally distributed. PER 
could not be normalized because its mode score was 0 (range, 0-35), and thus it was 
considered non-normally distributed in all analyses. 
The association analyses of DISC1 SNPs with psychosis proneness scales (Study III) 
were performed using independent samples.  The t-test was used for the normally 
distributed traits (RSAS, RPAS, SCHD) and the Mann-Whitney test for PER. 
Dominant and recessive genetic models were applied in the analyses. All tests were 
performed for the combined sample and for men and women separately. The 41 
SNPs were tested individually for association. To estimate the statistical significance 
of our findings, the Bonferroni correction was used.  
To test our primary hypothesis that the previously reported interplay among SNPs 
rs1538979, rs821577, and rs82163322 would hold true in our sample, the SNPs 
were further analyzed dependent on the absence and presence of risk alleles at the 
other two loci. The multiple minor alleles at these marker loci were analyzed against 
all others (marker combinations: rs1538979 and rs821577; rs821577 and rs821633; 
rs1538979 and rs821633; and rs1538979, rs821577, and rs821633). The minor 
alleles at only one of the three marker loci were analyzed against all others. No P-
value correction was performed for these tests because they were strictly hypothesis-
based. Effect sizes for the significant variants were estimated using Cohen d’ 
(Cohen 1988). 
Statistical tests in the genome-wide association study (Study IV) were performed 
using the genome-wide association analysis tool set PLINK (version 1.05) (Purcell 
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et al. 2007). We used linear regression and the additive genetic model to test for 
association between all the markers and RSAS and RPAS. We used the generally 
accepted limit of P < 5E-7 for genome-wide significance (Wellcome Trust Case 
Control Consortium 2007). The analyses were conditioned by DISC1 variants. All 
the analyses corrected for sex.   
 
4.4 Laboratory methods 
4.4.1 Genotyping methods and quality control 
In study I, we used previously genotyped genome-wide linkage data (Ekelund et al. 
2001, Ekelund et al. 2004, Paunio et al. 2001). The samples had been previously 
genotyped by the ABI 377 automated DNA sequencer (Applied Biosystems, Foster 
City, CA, US). 370 microsatellite markers have been genotyped in these families on 
the autosomes and chromosome X with an average spacing of 10.5 cM.  
In Studies I, II and III, SNP genotyping was performed using the Sequenom 
platform which is based on laser desorption ionization time-off-flight mass 
spectrometry (Sequenom Inc, San Diego, CA, US) according to the manufacturer’s 
recommendations (Jurinke et al. 2001). In Study III, one additional marker was 
genotyped using 5’ nucleases method (Taqman protocol) (Applied Biosystems, 
Foster City, CA, US). SNPs were later rejected if they had a genotyping success 
rates < 80%. The Hardy-Weinberg disequilibrium test was performed for all SNPs. 
In Study IV, the genotyping was performed using the Illumina Infinum Assay and 
HumanCNV370-Duo marker set. SNPs with success rates < 95 % were excluded 
from the analyses. Only SNPs with MAF (minor allele frequency) > 0.05 were 
analyzed. Individuals with genotyping success rates < 95 % were also excluded from 
the analyses. After quality controls, 331 307 out of a total of 339 054 SNPs and 
5251 individuals were included in the analyses. We had phenotypic information 
available for 4516 individuals of the individuals. 
 
4.5 Ethical consideration 
This study has followed the declaration of Helsinki and its amendments in full 
(World Medical Association. 2001). The study has been proved by Ministry of 
Social Affairs (Finland) and appropriate institutional review boards. 
All the participants in the study have provided their written informed consent. 
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To ensure the anonymity of the individuals participating in the study, all the 
individuals have been given a code that is used in all stages of the study and data 
handling. No data allowing for the identification of study subjects have been used in 
the study. Only certain researches are allowed to access the sensitive original 
personal information. 
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5 Results and discussion 
5.1 Conditioned genome-wide linkage study on 
schizophrenia (Study I) 
Since schizophrenia is a complex disorder with multiple genetic factors interacting 
in the background, we hypothesized that by conditioning our sample on the 
previously recognized DISC1 susceptibility variants we would be able to recognize 
new potential schizophrenia susceptibility loci. We performed a genome-wide 
linkage study conditioned on the previously recognized allelic haplotype of DISC1 
(HEP3). This haplotype previously displayed evidence for association with 
schizophrenia and memory functions in the Finnish schizophrenia family sample 
(Hennah et al. 2003, Hennah et al. 2005).  
Linkage with the DISC1 locus was first detected using 168 families. Due to an 
increase in sample size since the original study, the present study takes advantage of 
data from 458 families. We first performed an un-stratified analysis of the new, 
whole data set to qualify the previous linkage findings. In the unconditioned 
analyses two genomic loci displayed evidence for linkage (LOD > 3): marker 
D1S2709 intragenic of DISC1 and D5S647 on chromosome 5q12.3.  
The stratification was based on the HEP3 haplotype. Families with carriers of the 
HEP3 haplotype were analyzed as one group (N = 145) and non-carriers as another 
group (N = 313). After conditioning, three loci provided evidence for linkage (LOD 
> 3): 1q42 (D1S2709; LOD = 3.31, LC3), 10q21 (GATA101E02; LOD = 3.58, 
LC4) and 16p13 (D16S764; LOD = 3.17, LC1).  All three were within the sub-
sample of families carrying the DISC1 risk allele. In addition to these, nine loci 
displayed suggestive evidence for linkage (LOD > 2) in the stratified analyses. 
Results are summarized in table 9. 
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Table 9. HEP3 conditioned linkage scan, the most significant results. 
Location LOD score Sub-sample P-value Candidate genes 
1p13.2 2.2 HEP+ 0.69  
1q42 3.31 HEP+ 0.06 DISC1 
2q32.2 2.06 HEP+ 0.79  
5q12.3 2.59 HEP– 0.35  
6p21.2 2.16 HEP+ 0.71 DTNBP1 
7q22 2.25 HEP+ 0.64 GRM3, RELN 
8p22 2 HEP+ 0.83 NRG1 
8q24.13–q24.21 2.58 HEP– 0.36  
10q21.3 3.58 HEP+ 0.04  
11q22.3 2.8 HEP+ 0.22  
12q21.1 2.19 HEP+ 0.69 DAO 
16p13.11–p12.1 3.17 HEP+ 0.08 NDE1 
     
 
5.1.1 Conclusions 
In the conditioned analysis, we detected significant evidence for linkage on 
chromosome 16p13. In this region, 0.8 Mb from the best marker D16S764, a gene 
encoding a known DISC1-binding protein, NDE1, is located. Interestingly, this locus 
has also displayed evidence for linkage in Finnish bipolar disorder families (Ekholm 
et al. 2003), suggesting that the genomic locus might be of importance in the genetic 
etiology of other mental illnesses as well. 
Another marker that displayed significant evidence for linkage, D1S2709, is located 
within DISC1. It was expected that this marker would display a high LOD score in 
the conditioned analyses, because this marker showed the initial significant linkage 
in Finnish families and led to the discovery of the HEP3 haplotype, which was used 
here as the ascertainment criterion. The region where the GATA101E02 marker on 
chromosome 10q21 is located has previously displayed significant linkage to 
schizophrenia in Ashkenazi Jews (Fallin et al. 2003) and suggestive evidence in 
other studies (Levinson et al. 1998, Mowry et al. 2000). Based on the current 
knowledge, this region does not include any known schizophrenia or DISC1 
pathway genes. However, in this region (< 5 kb from the marker) two non-coding 
genes are located (HBII-419 and MIR1254). It might be of interest to study these 
RNA genes for their involvement in the etiology of mental illnesses. 
Altogether, we detected at least suggestive evidence for linkage (LOD > 2) within 
12 genomic regions. Of all these loci, ten are located at or within 50 cM from 
genomic regions previously identified in the linkage studies of schizophrenia. The 
ten loci included the genome regions containing the most promising schizophrenia 
candidate genes at the time: DTNBP1 (6p21) (Straub et al. 2002), NRG1 (8p22) 
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(Stefansson et al. 2002), GRM3 (Fujii et al. 2003) and RELN (7q22) (Impagnatiello 
et al. 1998). Increasing evidence for these genes supports their roles in the etiology 
of schizophrenia (Schwab et al. 2009, Harrison et al. 2008). Furthermore, many of 
these genes are parts of DISC1 related pathways. RELN interacts with DISC1 
through ApoER2 (LRP8) and PAFAH1B1 (LIS1) contributing to neuronal migration 
(Wynshaw-Boris et al. 2001, Assadi et al. 2003). GRM3 interacts with DISC1 
through RANBP9 and DTNBP1 through DMD or UTRN (Ingenuity Pathway 
Analysis). DISC1 and NRG1 have also been suggested to be functionally convergent 
(Jaaro-Peled et al. 2009). These observations further strengthen the importance of 
these observations and suggest that this kind of conditioned approach is a valid tool 
for the recognition of new susceptibility genes.  
 
5.2 DISC1 pathway candidate gene association 
studies (Studies I and II) 
5.2.1 NDE1 (Study I) 
We followed up the linkage on 16p13 near the DISC1 binding partner NDE1 by 
genotyping SNP markers spanning the NDE1-gene. Seven single nucleotide 
polymorphisms (SNPs) over 75 kb of the NDE1 gene were genotyped and 
association between these SNPs as well as the 4-SNP tag haplotype was analyzed. 
SNPs rs6498567, rs881803 and the tag haplotype displayed evidence for association 
with schizophrenia after 100 000 permutations with P-values of 0.0086, 0.021 and 
0.0065, respectively. However, none of these remained significant after the 
Bonferroni correction.  
Since DISC1 had previously displayed sex-dependent effects, we wanted to test 
whether such effects may also affect the association with the NDE1. All the SNPs 
and the tag-haplotype displayed P < 0.05 after 100 000 permutations when the 
females were analyzed alone. No evidence for association was detected when the 
transmission to only male offspring was monitored. After Bonferroni correction for 
the 24 tests performed, the female-specific association to the tag-haplotype 
(permutated P-value = 0.00046; observed transmissions = 237; expected 
transmissions = 208) remained significant (P = 0.011). The risk allele of the NDE1 
tag-haplotype comprised the CGCC alleles of the SNPs rs4781678, rs2242549, 
rs881803 and rs2075512, respectively. This haplotype was present in the founders of 
the schizophrenia families at a frequency of 30 %, whereas in the population control 
sample its frequency was 19 %. To account for the possible confounding effects 
linkage might have on the result in the family sample, an additional haplotype 
association analysis was performed using only one affected offspring per family in 
the analyses. The tag-haplotype remained significant after this test only among 
affected females (P = 0.0024), but was not significant in the whole sample (P = 
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0.072). However, this might be due to reduction in sample size (N = 1494 
individuals compared with 2756 in the whole sample). 
To test whether the NDE1 tag-haplotype explains the observed linkage, an additional 
linkage analysis was performed. Within the whole sample, the NDE1 tag-haplotype 
provided greater evidence for linkage than the microsatellite D16S764 (LOD = 1.00, 
compared to LOD = 0.78, respectively). However, when the families carrying the 
DISC1 risk haplotype HEP3 were analyzed separately, the NDE1 haplotype 
provided evidence for linkage with LOD-score of 1.26 while the closest 
microsatellite D16S764 displayed LOD = 3.17. This suggests that other nearby 
variants may have also partially contributed to the observed linkage signal.  
DISC1 has previously displayed evidence within this same family sample for 
association with visual working memory, a neurocognitive endophenotype for 
schizophrenia (Hennah et al. 2005). Because NDE1 is involved in the same pathway 
with DISC1, we hypothesized that NDE1 might contribute to the same phenotype. 
We looked for association between visual working memory and the NDE1 tag 
haplotype, which was the variant displaying the most significant evidence for 
association with affection status. Since measures of neurocognitive quantitative 
traits were available for only part of the schizophrenia family sample, we first 
analyzed the association with the end-state diagnosis in order to assess the effect of 
the reduced sample size (N = 215 families out of 458 families of the complete study 
sample). In this quantitative trait sub-sample, NDE1 tag-haplotype displayed P = 
0.046 when the whole sample was analyzed and P = 0.016 when only the females 
were included in the analyses. The NDE1 tag-haplotype did not provide evidence for 
association with visual working memory. Permutated P-values for the whole sample, 
females and males were 0.083, 0.055 and 0.15, respectively. 
Table 10: Observed P-values for the SNPs within NDE1 and the NDE1 
spanning tag-haplotype. P-values are provided for both association tests 
between schizophrenia diagnosis and visual working memory. 
  Outcome measure P All P Males P Females 
Whole schizophrenia family sample  
rs4781678* Schizophrenia diagnosis 0.051 0.66 0.0052 
rs6498567 Schizophrenia diagnosis 0.0086 0.48 0.0024 
rs2242549* Schizophrenia diagnosis 0.27 0.4 0.018 
rs881803* Schizophrenia diagnosis 0.021 0.53 0.0013 
rs1050162 Schizophrenia diagnosis 0.17 1 0.014 
rs2075512* Schizophrenia diagnosis 0.078 0.53 0.0044 
rs11130 Schizophrenia diagnosis 0.34 0.44 0.023 
*Tag haplotype Schizophrenia diagnosis 0.0065 0.93 0.00046 
Quantitative trait sub-sample       
*Tag haplotype Schizophrenia diagnosis 0.046 0.25 0.016 
*Tag haplotype Visual working memory 0.083 0.15 0.055 
  
 
THL – Research 37 70  The DISC1 Pathway in the  
Genetic Etiology of Schizophrenia 
5.2.2 Association analysis of 11 DISC1 binding partners (Study II) 
We continued to study the DISC1 pathway in the etiology of schizophrenia by  
studying 11 additional DISC1 binding partners to association with schizophrenia. 
We analyzed SNP markers and haplotypes for association with schizophrenia using 
a two-stage study design with random sampling of our original Finnish families. The 
number of families available for the study was 476. Association analyses between 
the affection status and SNPs and haplotypes were first performed in an exploratory 
sample of 171 families. The SNPs and haplotypes displaying evidence for 
association with P-values <0.05 were reanalyzed in a replication sample set 
consisting of 305 independent families. Markers and haplotypes passing the 
replication criteria in the second stage were analyzed with both sample sets 
combined.  
In stage one, 14 SNPs and 19 haplotypes in NDEL1, PDE4B, PDE4D, PAFAH1B1, 
MAP1A, and TRAF3IP1 displayed P-values < 0.05, and thus met our criterion for 
progressing to stage two. No markers or haplotypes in FEZ1, PCNT, TUBA1A, 
ATF4, and ATF5 met this criterion (Table 11). In stage two, SNP rs17806986 in 
NDEL1 and a NDEL1 spanning tag haplotype displayed evidence for association 
with P-values of 0.003 (in stage I P = 0.022) and 0.007 (stage I P = 0.005), 
respectively. Within PDE4B, two allelic haplotypes within the same LD block 
displayed replicated evidence for association CCC and CTT alleles of SNPs 
rs4503327, rs2503222 and rs6588186 with P-values of 0.048 (Stage I P = 0.029) and 
0.025 (Stage I P = 0.001), respectively. Further, SNP rs7412571 located in the 
neighboring LD block displayed evidence for association with a P-value of 0.048 
(stage I P = 0.028). Within PDE4D, replicated association was detected with an 
allelic haplotype spanning the haplotype of SNPs rs13190249, rs1120303, rs921942, 
rs10805515 and rs10514862 with P-value of 0.001 (Stage I P = 0.0059). SNP 
rs1120303 also displayed an independent effect on schizophrenia with P-values of 
0.006 and 0.027 in stages II and I, respectively. Markers and haplotypes displaying 
significant evidence for association in Stage II were tested for their overall 
significance in the combined sample set. The results of the combined sample are 
presented in Table 12.  
DISC1, NDE1 and other DISC1 binding partners have displayed gender differences 
in previous genetic association studies (Hennah et al. 2003, Pickard et al. 2007, 
Hennah et al. 2007). We tested for any potential gender differences by comparing 
allelic frequencies of the associating variants between males and females in our 
sample. We detected no differentiating effects between female and male offspring in 
the Finnish families. 
Some of the affected individuals in the sample are siblings. We wanted to account 
for the possible confounding effect of linkage by performing the haplotype 
association analysis by only using one affected offspring per family in the analyses. 
Three of the four haplotypes remained significantly associated with the following P-
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values: PDE4D = 0.0055, NDEL1 = 0.0018, and PDE4B protective and risk = 
0.0025 and 0.070, respectively.  
DISC1 has previously shown association with visual working memory in our family 
sample (Hennah et al. 2005) and other quantitative neurocognitive traits in other 
sample sets (Cannon et al. 2005, Blackwood et al. 2001, Thomson et al. 2005a). We 
wanted to test if our newly identified variants also have similar effects on the traits. 
In addition to visual working memory, we included several learning- and memory-
related variables in the analyses. Due to the smaller size of the neuropsychologically 
tested sample, we tested all the recognized SNPs and haplotypes in the combined 
sample only. Of the seven variants, none associated significantly (P < 0.05) with any 
of the nine traits tested. 
Table 11: The table summarizes the 11 DISC1 binding partners studied. 
    SNPs, P < 0.05 Haplotypes, P < 0.05 
Gene SNPs Stage 1 Stage 2 Stage 1 Stage 2 
ATF4  -   -   -   -   -  
ATF5 4 0  -  0  -  
FEZ1 6 0  -  0  -  
PCNT 10 0  -  0  -  
PAFAH1B1 6 0  -  1 0 
MAP1A 5 0  -  1 0 
TRAF3IP1 7 2 0 2 0 
NDEL1 4 4 1 2 1 
PDE4B 34 3 1 5 2 
PDE4D 69 5 1 8 1 
TUBA-1A 2 0 0 0  -  
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Table 12: The table summarizes findings in the combined sample for all the 
SNPs and haplotypes that passed the replication in stage 2. 
    SNPs  Haplotypes 
Gene  SNP P FA FC  Global P Alleles P FA FC 
NDEL1 rs17806986 0.0038 0.27 0.37  0.033 CGCG 0.0027 0.12 0.19 
Block 1 rs1391768 nt nt nt            
  rs1391766 nt nt nt            
  rs3817330 nt nt nt            
PDE4B rs4503327 nt nt nt  0.006 CCC 0.029 0.28 0.21 
Block 4 rs2503222 nt nt nt    CTT 0.0022 0.02 0.06 
  rs6588186 nt nt nt            
PDE4B rs10158178 nt nt nt  nt nt       
Block 5 rs7412571 0.018 0.45 0.35            
  rs599235 nt nt nt            
  rs2069278 nt nt nt            
PDE4D rs13190249 nt nt nt  0.0034 GGACA 0.00084 0.40 0.28 
Block 15 rs1120303 0.021 0.13 0.19            
  rs921942 nt nt nt            
  rs10805515 nt nt nt            
  rs10514862 nt nt nt            
nt: not tested 
 
5.2.3 Conclusions 
In the present study, we found evidence for significant association between SNP and 
haplotype variants in NDE1, NDEL1, PDE4B and PDE4D and schizophrenia. We 
found no evidence for association between ATF4, ATF5, FEZ1, MAP1A, 
PAFAH1B1, TRAF3IP1, PCNT or TUBA1A and schizophrenia. 
PDE4B is currently the most studied of the DISC1 pathway genes after DISC1 itself. 
At present, the SzGene database ranks PDE4B as the fourth best candidate gene for 
schizophrenia based on association evidence (Allen et al. 2008). After the initial 
report on the connection between PDE4B and schizophrenia (Millar et al. 2005), 
four studies in addition to ours have reported positive association between 
schizophrenia and the gene (Pickard et al. 2007, Fatemi et al. 2008a, Numata et al. 
2008, Kahler et al. 2010). However, negative association findings have also been 
reported (Rastogi et al. 2009, Holliday et al. 2009). In the SzGene meta-analysis, 
SNP rs910694 displayed significant association with schizophrenia. This SNP was 
not included in our study and other SNPs in the same region did not display 
evidence for association in our study. However, previous studies by Pickard et al 
and Fatemi et al reported associating variants at the same loci with which we 
detected association (Pickard et al. 2007, Numata et al. 2008). 
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We are the only study reporting association between PDE4D and schizophrenia to 
date. However, PDE4D has displayed evidence for association with neuroticism in 
several reports (Shifman et al. 2008, Heck et al. 2008, Calboli et al. 2010). 
Neuroticism is a moderately heritable personality trait and is considered to be 
associated with a risk for developing major depression, anxiety disorders and 
dementia (Calboli et al. 2010). Like DISC1, PDE4D might thus be involved in the 
etiology of a wide spectrum of mental disorders. Thus, studying the association 
between PDE4D and other mental disorders would be of interest. Further, 
association between PDE4D and schizophrenia has to be verified in other samples 
and populations.  
A haplotype within NDEL1, consistent with our finding, has also previously 
displayed evidence for association with schizophrenia in US Caucasian population 
(Burdick et al. 2008). Furthermore, significant interplay between NDEL1, NDE1 and 
DISC1 has been reported (Burdick et al. 2008). These findings suggest competitive 
binding between NDE1 and NDEL1. In other independent studies, SNPs in NDE1 
have not displayed evidence for association with schizophrenia. However, in our 
study the strongest association was found with haplotypes. 
In the present study, we took the novel approach of studying candidate genes for 
schizophrenia based on information on their interaction with DISC1 and their 
molecular functions. Even though we did not detect evidence for association with 
the other candidate genes studied, other groups have reported positive findings 
between schizophrenia and PCNT (Numata et al. 2009a, Anitha et al. 2009) and 
FEZ1 (Yamada et al. 2004). However, despite the attempts, other association studies 
have failed to detect association between FEZ and schizophrenia (Rastogi et al. 2009, 
Koga et al. 2007, Hodgkinson et al. 2007). 
DISC1 has previously displayed an association with visual working memory in the 
same Finnish sample we used for studying NDE1, NDEL1, PDE4B and PDE4D. 
However, schizophrenia susceptibility variants within these genes did not display 
evidence with the tested learning and memory related endophenotypes. It is likely  
that these genes contribute similarly in the etiology of schizophrenia since these 
genes are involved in the same intracellular pathways. Thus, is would have been 
expected to detect an association between these genes and working memory as well. 
One reason for lack of association might be lack of power due to inadequate sample 
size. 
Our findings support other reports on the DISC1 binding partners, and thus support 
the involvement of NDE1, NDEL1, PDE4B and PDE4D in the etiology of 
schizophrenia.  
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5.3 DISC1 and psychosis proneness (Study III) 
5.3.1 Exploratory analyses 
In Study III, we studied the association between variants in DISC1 and psychosis 
proneness measures in the general population. We genotyped 41 SNPs covering the 
DISC1-TSNAX region. All 41 SNPs were tested for association with four variables: 
Revised Social Anhedonia Scale (RSAS), Revised Physical Anhedonia Scale 
(RPAS), Perceptual Aberration Scale (PER) and Golden and Meehl Schizoidia Scale 
(SCHD).  Association analyses applied both dominant and recessive genetic models. 
SNP rs821577 displayed significant association after correcting for multiple testing 
in the combined sample under the dominant genetic model. Carriers of the minor 
allele of this SNP had significantly higher scores in RSAS (P = 0.000021) in the 
combined sample (minor allele frequency, MAF = 0.44). Females contributed more 
to the statistical significance when gender-specific analysis was performed (P = 
0.00019 in females and P = 0.040 in males). Modest uncorrected association 
showing higher scores in RPAS were detected in the combined (P = 0.021) and 
female samples (P = 0.0056). SNPs rs11122381 and rs821592 displayed significant 
recessive effects on RSAS when females were analyzed separately. Carriers of the 
minor alleles of these SNPs had significantly lower scores in RSAS with P-values of 
0.0000038 for rs11122381 and 0.000042 for rs821592. As the threshold to maintain 
a Type I error rate of α = 0.05 after multiple testing correction was uncorrected P < 
0.000053, these three SNPs remained significant even after correction: marker 
rs821577 when analyzed in the combined sample and markers rs11122381 and 
rs821592 when females where analyzed separately. The significant findings are 
summarized in Figures 10 and 11a. 
Even though no other SNPs remained significant after the multiple testing 
correction, SNP rs821616 that has previously associated with schizophrenia and 
cognitive aging (Qu et al. 2007, Kim et al. 2008, Thomson et al. 2005a, Callicott et 
al. 2005) displayed modest uncorrected association with lower scores in SCHD in 
our sample. P-values in both combined and male samples were 0.022 (MAF = 0.32).  
5.3.2 Replication of the previously reported interplay between three SNPs 
Our main goal in Study III was to test our a priori hypothesis of interplay between 
three DISC1 SNPs. A previous study described a modulation of effect when SNPs 
rs1538979, rs821577 and rs821633 were reanalyzed conditioned on the genotypes of 
the other SNPs. These SNPs significantly associated with schizophrenia and bipolar 
disorder (Hennah et al. 2009b). Since the SNPs were the only SNPs displaying 
significant interplay in the previous study, we restricted our interplay testing to these 
SNPs. Significant association was detected again with both RSAS and RPAS, but 
not with PER or SCHD. When the risk allele of SNP rs821577 was accompanied by 
the minor (C) allele of SNP rs821633, association with RSAS was detected in the 
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combined and female samples (P = 0.00054, frequency (f) = 0.468 in the combined 
sample and P = 0.00097, f = 0.467 in females), with carriers of these alleles having 
significantly higher scores on the variables). This combination of alleles was also 
modestly associated with RPAS when females were analyzed separately (P = 0.019) 
and also approached significance in the combined sample (P = 0.067), again with the 
carriers having higher scores. When the SNPs were tested conditioned on the 
absence of the minor alleles of the other two SNPs, the minor allele of SNP 
rs821633 (f = 0.211) associated significantly with lower scores in both RSAS and 
RPAS. P-values in the combined sample for RSAS and RPAS were 0.0000022 and 
0.0075, respectively. Significant association with RSAS was also detected when 
females and males were analyzed separately (P = 0.00031 for females, f = 0.220 and 
P = 0.011 for males, f = 0.199). Furthermore, RPAS associated significantly with 
this marker in females (P = 0.0086). The significant findings are summarized in 
Figures 10, 11b and 11c. 
 
 
Figure 10. The schematic describes the study setting in Study III. As an a priori 
hypothesis three SNPs were studied for association with measures of psychosis 
proneness. In exploratory analyses, two additional SNPs displayed significant 
evidence for association. 
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 a) 
 
b) 
 
c) 
 
Figure 11. Mean values, 95% confidence intervals and corrected P-values for 
the significant markers on the Revised Social Anhedonia Scale in the 
exploratory analyses (a), and summary of the findings in the conditioned 
analyses for Revised Social Anhedonia Scale (b) and the Revised Physical 
Anhedonia Scale (c). 
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5.3.3 Conclusions 
In the present study, we detected association between variants in DISC1 and 
measures of anhedonia. A previous study by Hennah and colleagues had reported 
that three interdependent SNPs in DISC1 contribute to the risk of schizophrenia and 
bipolar disorder. We were able to partially replicate this finding with the same 
variants in our study associating with measures of physical and social anhedonia. 
Additionally, we detected female-specific associations with two other SNPs in the 
exploratory analyses. 
The exploratory association tests were corrected for multiple testing using the 
Bonferroni correction. This correction is obviously overly conservative because the 
studied phenotypes and markers are not independent of each other, association in the 
two sexes is not independent and dominant and recessive analyses are not 
independent. We preferred to err on the side of caution in our interpretation by using 
the overly conservative cutoff. 
Our study was the first to report association between schizophrenia-related traits and 
DISC1 at the population level. This notably adds to the previous evidence of 
DISC1’s important role in the etiology of schizophrenia. To estimate the gene’s 
effects in the general population, unselected population cohorts have to be studied. 
Performing diagnostic and neuropsychological tests and subsequently looking for 
association between schizophrenia and the gene variants in large cohorts is difficult. 
First of all, given the prevalence of schizophrenia in the general population (1 %), 
unfeasibly large sample sizes are required. Performing diagnostic tests in such large 
cohort would require large resources. We avoided large costs by using validated 
pen-and-paper questionnaires. The ability of these scales to predict later onset 
psychotic disorders has been studied on a large scale. Both physical and social 
anhedonia are suggested to be efficient in predicting the onset of psychotic disorders 
later in life (Horan et al. 2008, Fonseca-Pedrero et al. 2009).  
Naturally, not all individuals who score high on the scales develop psychotic 
disorders. However, the scales have no “normal” limit. Our findings suggest that 
DISC1 might have an impact on how people psychologically react. Therefore, 
DISC1 might be even more central to human psychological functioning than 
previously thought. 
Our findings also support the idea of a complex interplay among genetic variants in 
the genetic background of schizophrenia. SNP rs821633 only displayed a significant 
effect when conditioned on two other SNPs. 
In the exploratory analyses, we detected female-specific association with markers 
rs11122381 and rs821592. This region has been previously implicated in 
schizophrenia by Qu and colleagues who detected significant association between 
schizophrenia and a haplotype overlapping this region. Furthermore, these markers 
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are located in close proximity to the non-synonymous SNP rs821616. This SNP has 
associated with schizophrenia and related phenotypes in many previous studies (Qu 
et al. 2007, Kim et al. 2008, Thomson et al. 2005a, DeRosse et al. 2007) and 
displayed uncorrected evidence for association with the schizoidia measure in the 
present study. 
DISC1 has been especially connected to the negative symptoms of schizophrenia. 
Variants in DISC1 have previously displayed association with schizophrenia related 
learning and memory deficits also in the Finnish schizophrenia family (Hennah et al. 
2005). Learning and memory deficits are also closely related to the negative aspects 
of schizophrenia. Our findings further strengthen the theory that DISC1 is important 
in the negative aspects of schizophrenia.   
 
5.4 DISC1 conditioned genome-wide association 
study on psychosis proneness (Study IV) 
The number of DISC1 binding partners displaying evidence of involvement in the 
etiology of schizophrenia is increasing and 16 of the 27 known DISC1 binding 
partners studied display evidence of involvement in the etiology of schizophrenia 
(Table 5, page 53). After finding strong evidence for association with anhedonia 
using the same DISC1 variants that had previously associated with schizophrenia 
and bipolar disorder, we wanted to utilize these variants to recognize new DISC1-
related susceptibility variants. We used a similar strategy as in Study I and 
conditioned a whole genome-wide SNP association analysis on the DISC1 variants. 
We utilized the NFBC66 sample and the measures we previously detected 
association with: RSAS and RPAS. As in the study that identified NDE1, we 
hypothesized that with these genetically more homogeneous stratified samples we 
would be more likely to recognize variants with small effect sizes related to 
psychosis proneness that potentially interact with DISC1.  
Association analyses between SNPs (a total number of SNPs: 331 307) and traits of 
social and physical anhedonia were performed in the whole sample using DISC1 
variants as covariates and separately in the three groups defined by individuals’ 
DISC1 variants. The number of individuals belonging to different DISC1 variant 
groups were as follows: DISC1 risk variant (N = 3049), DISC1 protective variant (N 
= 962), and neutral DISC1 variant (N = 505). In the analysis with DISC1 as a 
covariate, a new variable based on the carried DISC1 variants was created to be used 
as a covariate in the analyses. 
No markers reached genome-wide significance at the level of P < 5E-7 using any of 
the models tested. To see if we observed lower p-values than expected by chance, P-
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values were plotted in quantile-quantile plots (QQ-plots). No notable inflation from 
the level expected by chance was observed under any of the models tested (Figure 
12). However, when the results were illustrated by plotting the –log P-values against 
all SNPs in order of their chromosomal positions (Manhattan plots) to observe any 
local clustering of low P-values, a number of suggestive clusters were observed 
(Figure 13). We followed up 18 of the most consistent clusters where at least three 
SNPs displayed P < 1E-4 by mapping the closest genes (UCSC Genome Browser, 
NCBI Build 36.1). SNPs with P-values < 1E-4 located in consistent clusters are 
presented in Table 13 together with information on their closest genes. 
 
a) 
1)           2)  3)    4)
 
b)  
1)              2)                    3)  4)
 
Figure 12. The schematics show the QQ plots for the observed –log10 P-values 
versus those expected by change for Revised Social Anhedonia Scale (a) and 
Revised Physical Anhedonia Scale (b) risk (1), protective (2), neutral (3) and 
covariated (4) models. 
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 a)                    *                                                 * 
 
b)                                                              ** 
 
c)                                                      *                           *   
 
d)                      *                   *                                   *                             *     
 
 
 
 
 
 
 
 
 
Figure 13. Manhattan plots for all the tested models: RPAS risk (a), RPAS 
protective (b), RPAS neutral (c), RPAS covariated (d), RSAS risk (e), RSAS 
protective (f), RSAS neutral (g), RSAS covariated (h). Blue line corresponds to 
P = 10 E-4. The clusters with ≥ 3 SNPs with P < 10E-4 are marked with 
asterisk (*). 
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e)                 * 
 
f)                                                                                           *     *
 
g)              
 
h)                                   *      *                 *   *                                     *   
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Table 13. Summary of the SNPs displaying P-values <1E-4 located within 
clusters having consistently low P-values.  For all the SNPs, the closest gene and 
the distance to the gene in base pairs are indicated. 
Model Chr rs-number 
Position 
(bp) 
P-value A MAF 
Closest 
gene 
Dist 
(kb) 
RSAS R 2 rs4953223 45370846 1.49E-06 G 0.385 UNQ6975 65 
RSAS R 2 rs4953225 45374689 2.53E-05 G 0.340 UNQ6975 61 
RSAS R 2 rs883413 45383099 3.67E-05 A 0.336 UNQ6975 52 
RSAS P 14 rs2145631 95480113 8.97E-06 G 0.179 BC016484 35 
RSAS P 14 rs999200 95488632 1.06E-05 C 0.181 BC016484 27 
RSAS P 14 rs1998245 95498331 4.72E-05 A 0.238 BC016484 37 
RSAS P 16 rs8062856 67640318 2.28E-05 A 0.453 TMCO7  0 
RSAS P 16 rs11075704 67648719 5.30E-06 G 0.409 TMCO7  0 
RSAS P 16 rs2232228 67701078 3.58E-05 G 0.365 HAS3  0 
RSAS P 16 rs3785079 67702977 1.82E-05 A 0.331 HAS3  0 
RSAS C 4 rs370655 75121998 5.61E-05 G 0.334 CXCL3 0 
RSAS C 4 rs9131 75181913 3.43E-05 G 0.336 CXCL2 0 
RSAS C 4 rs3806792 75184138 7.11E-05 A 0.332 CXCL2 0 
RSAS C 5 rs10515379 107167562 3.13E-05 A 0.375 FBXL17 56 
RSAS C 5 rs6888461 107174573 4.15E-05 A 0.386 FBXL17 49 
RSAS C 5 rs7700475 107186057 4.31E-05 A 0.251 FBXL17 37 
RSAS C 8 rs7833633 35529967 4.12E-05 G 0.069 UNCD5 0 
RSAS C 8 rs6980691 35531940 4.23E-05 C 0.069 UNCD5 0 
RSAS C 8 rs983271 35534194 4.33E-05 G 0.067 UNCD5 0 
RSAS C 9 rs4554557 84714350 2.41E-05 A 0.178 RASEF 73 
RSAS C 9 rs12340476 84730049 8.71E-06 A 0.173 RASEF 57 
RSAS C 9 rs17085898 84757459 2.92E-05 A 0.156 RASEF 30 
RSAS C 19 rs8110509 6.35E-06 A 0.243 ZNF536 0 
RSAS C 19 rs919803 35678944 3.52E-05 G 0.296 ZNF536 0 
RSAS C 19 rs3786791 35718715 1.27E-05 A 0.271 ZNF536 0 
RPAS R 2 rs2305165 136126044 2.14E-05 C 0.092 R3HMD1 0 
RPAS R 2 rs4954633 136263105 1.84E-06 A 0.102 LCT 0 
RPAS R 2 rs2874874 136294664 1.01E-05 C 0.111 LCT 0 
RPAS R 2 rs3754690 136307028 1.31E-05 A 0.112 LCT 0 
RPAS R 2 rs309126 136360370 4.02E-05 G 0.129 MCM6 10 
RPAS R 10 rs10509494 86142888 5.36E-05 A 0.077 KIAA1128 0 
RPAS R 10 rs1763976 86247427 7.91E-05 A 0.077 KIAA1128 0 
RPAS R 10 rs1777112 86251786 7.92E-05 A 0.078 KIAA1128 0 
RPAS R 10 rs1188774 86297467 7.73E-05 A 0.073 KIAA1128 29 
RPAS P 8 rs199215 140800438 6.14E-05 A 0.160 TRAPPC9 11 
RPAS P 8 rs199231 140811036 2.49E-05 A 0.158 TRAPPC9 1 
RPAS P 8 rs898663 140819354 2.49E-05 C 0.156 TRAPPC9 0 
RPAS P 8 rs11773968 140840193 5.38E-05 A 0.068 TRAPPC9 0 
RPAS P 8 rs11781035 140840343 3.69E-05 A 0.150 TRAPPC9 0 
RPAS P 9 rs2997564 7444698 8.79E-05 C 0.334 C9orf123 34 
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Model Chr rs-number 
Position 
(bp) 
P-value A MAF 
Closest 
gene 
Dist 
(kb) 
RPAS P 9 rs2997570 7450556 2.19E-05 A 0.351 C9orf123 34 
RPAS P 9 rs2765970 7452518 2.19E-05 C 0.351 C9orf123 33 
RPAS P 9 rs1926370 7461079 5.36E-05 G 0.463 C9orf123 33 
RPAS N 7 rs11766051 55806039 2.59E-05 A 0.133 PSPHL 2 
RPAS N 7 rs10243293 55809594 2.73E-05 A 0.136 PSPHL 1 
RPAS N 7 rs6966061 55816284 2.44E-05 G 0.133 PSPHL 8 
RPAS N 7 rs9642404 55824293 1.46E-05 A 0.157 SEPT14 4 
RPAS N 7 rs1113765 55856828 9.59E-05 A 0.256 SEPT14  0 
RPAS N 7 rs10230845 55873390 2.11E-05 A 0.139 SEPT14  0 
RPAS N 7 rs11761352 55918441 6.33E-05 A 0.152 MRPS17 4 
RPAS N 7 rs10271662 55930401 8.36E-05 C 0.164 MRPS17 0 
RPAS N 12 rs11610671 114895945 3.86E-06 A 0.231 MED13L 0 
RPAS N 12 rs10507268 115024610 1.39E-05 A 0.237 MED13L 0 
RPAS N 12 rs11615689 115184058 2.24E-06 G 0.234 MED13L 0 
RPAS C 2 rs4894030 179169467 9.40E-05 C 0.176 TTN 0 
RPAS C 2 rs2046778 179380792 1.67E-05 G 0.170 TTN 0 
RPAS C 2 rs1873164 179461794 4.82E-05 G 0.253 CCDC141 0 
RPAS C 5 rs319131 103353873 6.45E-05 A 0.418 NUDT12 427 
RPAS C 5 rs6892281 103547741 9.52E-05 G 0.394 NUDT12 621 
RPAS C 5 rs3931126 103561783 9.54E-05 A 0.394 NUDT12 635 
RPAS C 12 rs4768236 39042739 2.29E-06 C 0.263 LRRK2 0 
RPAS C 12 rs3761863 39044919 3.34E-06 A 0.260 LRRK2 0 
RPAS C 12 rs9668854 39105985 6.46E-05 A 0.094 LRRK2 57 
RPAS C 22 rs929014 31488023 4.24E-05 A 0.210 SYN3 0 
RPAS C 22 rs2899194 31497851 2.47E-05 A 0.242 SYN3 0 
RPAS C 22 rs130559 31518536 9.28E-05 A 0.231 SYN3 0 
 Abbreviations: RSAS: Revised Social Anhedonia Scale, RPAS: Revised Physical Anhedonia Scale, 
Chr: chromosome, A: minor allele, MAF: minor allele frequency, dist kp: distance to the closest gene 
in kilo base. 
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a) 
 
b)  
 
c) 
 
Figure 14. The schematics show the regions with suggestive evidence for 
association on 2q31.2 (a), 2q21.3 (b) and 12q24.21 (c). The figures are based on 
UCSC genome browser information as of March 2006 (NCBI36/hg18). All the 
SNPs genotyped on the regions are indicated with vertical lines. For the SNPs 
with P < 1E-4 the rs-numbers are also provided. Genes (UCSC Genes) and 
miRNAs located within the regions are displayed. 
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To estimate the relevance of the genes displaying suggestive evidence for 
association in the DISC1 related pathways, we utilized the Ingenuity Pathway 
Analysis tools. Both direct and indirect connections between DISC1 and other 
DISC1 pathway genes as well as the genes displayed in Table 13 were studied. SNP 
rs1873164 on chromosome 2 that displayed evidence for association with RPAS (P 
= 4.82E-05, MAF = 0.253) in the analysis with DISC1 as a covariate is located 
within CCDC141 gene, which was shown to interact with DISC1 directly (Figure 
14c). Even though other genes could not be directly linked to DISC1 pathways 
through biological interactions, it has been previously shown that expression levels 
of LCT (rs4954633, P = 1.84E-06, MAF = 0.102) are influenced by variants in 
DISC1 (Figure 14a) (Hennah et al. 2009a).  
Recently many non-coding genes have been implicated in the etiology of 
schizophrenia and other major mental illnesses (Kocerha et al. 2009). Therefore, we 
wanted to see if non-coding genes are also implicated in the present study. We 
searched the UCSC database for non-coding micro RNA (miRNA), small nuclear 
RNA (sno-RNA) and small interfering (siRNA) genes located at the cluster regions. 
MiRNAs were located within two cluster regions. On chromosome 2q21.3 in close 
proximity to LCT, MIR128-1 is located (Figure 13b). In the 12q24.21 region, several 
markers displayed suggestive evidence for association with physical anhedonia only 
when the carriers of the neutral DISC1 variant were included in the analyses. Within 
this region, SNP rs11615689 displayed the strongest evidence for association (P = 
2.24E-06; MAF = 0.23). At this locus, MIR620 is located (Figure 14b).  
We studied the miRNAs’ predicted target sites. The predicted target sites were 
recognized using a publicly available database miRBase (Griffiths-Jones et al. 2008, 
Griffiths-Jones et al. 2006, Griffiths-Jones 2004). The miRNA MIR620 regulates the 
expression levels of 778 genes. In the Ingenuity pathway analysis, these genes were 
significantly enriched in pathways related to bipolar disorder (67 molecules; P = 
6.69E-06). Physiologically the second most enriched category is nervous system 
development (39 molecules). These genes included five genes (GABRA1, GRIK1, 
FOXP2, NUMBL and PCP4) that have been previously implicated in the etiology of 
schizophrenia through expression changes. MIR128-1 had 755 predicted target sites, 
but they did not display enrichment in pathways related to central nervous system or 
mental illnesses.  
5.4.1 Conclusions 
We performed a whole genome-wide scan conditioned on the DISC1 variants that 
associate with schizophrenia, bipolar disorder and psychosis proneness measures of 
physical and social anhedonia. The aim was to recognize new variants dependent on 
DISC1 that play roles in the etiologies of major mental illness. Even though no 
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significant association was detected, we detected some evidence for association 
within loci that have biological relevance in the etiology of schizophrenia.  
One of the most significantly associated genes was the LCT gene. It is suggested to 
be an indicator of population stratification due to large variation in allelic 
frequencies across different populations (Campbell et al. 2005, Epstein et al. 2007). 
In a previous study by Jakkula and colleagues (Jakkula et al. 2008), a substructure 
analysis using Eigensoft analysis methods (Patterson et al. 2006) was performed on 
the Finnish population. The analysis included a subset of SNPs used in the present 
study and the same population cohort was used as a subpopulation. For the variants 
recognized in the present study, the first two eigenvectors did not display any 
evidence for population stratification within our sample. 
Intriguingly, LCT is one of the target sites of miRNA MIR620 that is located in a 
genomic region displaying evidence for association under the DISC1-neutral model.  
Furthermore, in a previous report by Hennah and colleagues the expression level of 
LCT was influenced by DISC1 variants. 
Numerous miRNAs have been implicated in the etiology of schizophrenia and other 
mental illnesses. These include miR-9 and miR-124 involved in neuronal 
development, and miRNAs miR-134 and miR-138 involved in neuronal plasticity 
(Christensen et al. 2009). In our analysis, MIR620 displayed evidence for 
involvement in the etiology of mental illnesses. Predicted target sites of MIR620 
were enriched in central nervous system development pathways genes (Ingenuity 
Pathway Analysis). Five of the genes have been previously implicated in the 
etiology of schizophrenia because of their expression changes (Petryshen et al. 2005, 
Choi et al. 2009, Passos Gregorio et al. 2006, Fatemi et al. 2008b, Byne et al. 2009). 
Furthermore, the predicted target sites of MIR620 were also significantly enriched in 
the bipolar disorder pathways. Patients with bipolar disorder display elevated RPAS 
scores while relatives of affected individuals and healthy controls have similar 
scores (Etain et al. 2007). Therefore, RPAS is not considered a bipolar disorder 
endophenotype (Etain et al. 2007). However, a connection between RPAS and 
depression, a central symptom of bipolar disorder, has been suggested (Leventhal et 
al. 2006). Our findings might thus suggest that MIR620 has a role in the brain and in 
the etiology of mental illnesses by regulating numerous genes contributing to the 
onset of mental disorders  
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Figure 15. The schematic describes the most interesting findings and how they 
are related to DISC1 and biological functions/pathways in the background of 
schizophrenia.  
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6 Concluding remarks and future 
prospects 
We have studied the common variance in the genetic background of schizophrenia 
in a pathway-driven manner. We have studied the genes comprising one of the most 
promising candidate networks for schizophrenia: the DISC1 pathway. 
We utilized a novel conditioned genome-wide linkage approach to recognize new 
variants contributing to the onset of schizophrenia. By conditioning the study on a 
DISC1 risk variant HEP3 that was recognized in the Finnish families ascertained for 
schizophrenia, we detected significant linkage on a locus where a DISC1 binding 
partner NDE1 is located. Variants in NDE1 displayed significant independent 
association with schizophrenia within the same sample. We continued by studying 
other genes in DISC1 pathway using a candidate gene approach.  We selected the 
genes for study by evidence of their biological interaction between the gene products.  
We found strong evidence for the involvement of NDEL1, PDE4B and PDE4D in 
addition to NDE1 and DISC1 in the etiology of schizophrenia.  
We have also found important additional evidence for DISC1 itself. Variants in this 
gene associated significantly with anhedonia in the general healthy population. The 
associating variants were the same that previously displayed an allelic interplay that 
associated with both schizophrenia and bipolar disorder. This finding was important 
for at least two reasons. First, our replication strengthens the idea of a complex 
allelic interplay between genetic variants in the genetic background of schizophrenia. 
Secondly, with this finding, we were able to for the first time show an impact of 
DISC1 on a psychosis related trait in the Finnish general population. This way, 
DISC1 gene might be relevant, not only in terms of mental illness, but also in more 
general sense in psychological functioning. 
Finally, through DISC1-conditioned genome-wide association we recognized 
additional potentially interesting loci involved in the etiology of schizophrenia. LCT, 
CCDC141, MIR620 and MIR128-1 displayed evidence for DISC1-conditioned 
association with physical anhedonia. They provide promising new candidate 
molecules for further study in the genetic background of schizophrenia.  
In the present study, we have utilized intermediate phenotypes for schizophrenia in 
addition to studying genetic association with the schizophrenia diagnosis. These 
phenotypes included learning and memory related endophenotypes of schizophrenia 
and intermediate psychosis proneness measures. Endophenotypes are thought to 
result from a more simple genetic architecture compared to a clinical phenotype, and 
thus they facilitate the recognition of genetic susceptibility variants. 
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Endophenotypes might be the manifestation of the cellular and molecular changes 
(Benes 2007). However, the overlaps between endophenotypes and clinical 
phenotypes are significant in schizophrenia, other psychotic disorders and bipolar 
disorder (Benes 2007). Similarities in the clinical phenotype suggests that the 
respective endophenotypes may also show areas of overlap with respect to the 
circuitry involved and the nature of the cellular and molecular changes present 
(Benes 2007). 
The genetic etiology of schizophrenia is heterogeneous. Numerous different variants 
within the same genes have contributed to the risk in different samples. Therefore, it 
seems that numerous different variants within a number of genes can result in a 
similar phenotype. This might explain why meta-analyses have often failed to 
display congruent evidence for even the “best” candidate genes. This is the case for 
DISC1 and the DISC1 binding partners. When studying such a heterogeneous 
disorder, it is worthwhile to take advantage of an isolated population, such as the 
population of Finland. In such populations, the amount of genetic variation in the 
background of a certain disorder is assumed to be smaller than in a more mixed 
population, and thus the recognition of susceptibility variants and genes is easier.  
In today’s large-scale genome-wide studies, the amount of genetic data available for 
analysis has remarkably increased. The trend will continue into the future as 
genome-wide sequencing becomes a more easily accessible tool for genetic studies. 
This will create challenges for the analysis and interpretation of genetic data. Along 
with statistical significance, the pathway approaches we have utilized in the present 
study might help with the processing of massive amounts of data. Furthermore, the 
studies in the future will likely benefit from combining existing biological evidence 
with genetic data, especially when interpreting results and their significance. 
The ever increasing understanding of human genetic variation and non-coding genes, 
such as miRNAs and siRNAs, and their involvement in human diseases will provide 
new targets for genetic studies. Numerous miRNAs have already been implicated in 
psychiatric and neurodevelopmental disorders, including the miRNAs for which we 
detected association. However, the function of a large proportion of the DNA 
sequence is still unknown (so-called junk-DNA). New, advanced methods could 
eventually reveal the function of junk-DNA and provide new insights into the 
genetic mechanisms behind disorders.   
When the present study was initiated in 2005, only the genes DISC1, FEZ and 
PDE4B out of the large group of DISC1 binding partners had been implicated in the 
etiology of schizophrenia. Since then, the number of DISC1-related susceptibility 
genes implicated in the etiology of schizophrenia has been growing quickly. 
Intriguingly, in addition to the recognition of new schizophrenia candidate genes in 
these pathways, many of the “old”, strong candidate genes have shown to be closely 
related to DISC1 pathways. These include NRG1, RELN, AKT1 and COMT 
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(Nicodemus et al. 2007).  New, more efficient study techniques have enabled and 
will enable much more efficient genotyping of the candidate genes in the future. 
This will greatly facilitate the recognition of new susceptibility genes. 
The increasing understanding of biological interactions among genes and gene 
products will also facilitate genetic studies. It has already been shown that genetic 
interplay in the DISC1 pathway within genes (Hennah et al. 2009b) and between 
different genes (epistasis) (Burdick et al. 2008, Nicodemus et al. 2010) contribute to 
the risk of mental illnesses. As the understanding of biological interplay between 
genes and gene products increases, studying these interactions with respect to 
phenotypes becomes easier. It has been argued that studying single, independent 
SNPs for complex disorders is not optimal since the effect of genetic variation is 
dependent on the genetic environment. In the future, genetic studies will most likely 
study genetic networks rather than single genes.  
In addition to genetic interplay, gene x environment interactions (G x E) contribute 
significantly to mental illnesses. Thus, in the future, the studies of schizophrenia will 
emphasize complex interplay between genetic and environmental factors. Numerous 
significant gene x environment interactions have already been reported. These 
include interactions between obstetric complications and AKT1, GRM3, BDNF1 and 
DTNBP1 and cannabis use and COMT (Roth et al. 2009, Nicodemus et al. 2008, 
Caspi et al. 2005). DISC1 and the DISC1 pathway have not yet been explored for 
the gene x environment interactions, thus it would be of interest to study the genes 
and the variants we have recognized for interactions with environmental factors. 
Due to the involvement of the DISC1 in neuronal development, fetal infections or 
obstetric complications might provide phenotypes for studying such interactions.  
After our reports on the predisposing variants in NDE1, NDEL1, PDE4B and 
PDE4D, these variants have been shown to significantly affect expression levels of 
numerous genes significantly enriched in neurodevelopmental, synaptogenic and 
sensory perception gene ontology (GO) pathways. Intriguingly, several genes coding 
for proteins that are psychiatric drugs targets displayed altered expression rates 
dependent on variants in NDE1 and PDE4B (Hennah et al. 2009a). The PDE4s 
themselves are targets for rolipram, a medicine having antidepressant, antipsychotic 
and cognitive enhancement effects (Rose et al. 2005). Furthermore, AKT1 
interacting with DISC1 through GSK3β is a target for mood-stabilizer lithium (Ming 
et al. 2009). This suggests that the DISC1 pathway might offer targets for further 
drug development (Hennah et al. 2009a). Based on these findings, DISC1 pathway 
genes might even contribute to an individual’s response to the current psychiatric 
medication.   
The ultimate goal in genetic studies is naturally the recognition of functional 
variants behind the diseases. This would eventually enable better understanding 
about the studied disorders and enable the design of better or new treatments. The 
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present study does not provide any conclusive or definitive findings on DISC1 or the 
DISC1 pathway. However, our findings strongly support the role of the DISC1 
pathway in the etiology of schizophrenia and human mental functioning. In case of 
multifactorial, complex disorders it unlikely to recognize actual disease causing 
variants trough genetic association studies. Rather, the recognition of true variants 
requires more accurate genetic analyses such as sequencing. The growing evidence 
for especially DISC1 and also PDE4B would suggest that these genes might be good 
targets for more precise genetic analyses in the future (i.e. sequencing). The 
recognition of actual functional variants for a number of key molecules on the 
DISC1 pathways might facilitate recognition of remaining variants as well.  
By further understanding how DISC1 pathway genes possibly contribute to 
treatment outcomes and drug responses, it might be possible to target future 
medication more precisely. In schizophrenia, this would be a big step towards better 
treatment. Currently more that 20 % of schizophrenia patients do not initially 
respond to treatment with drug therapy. In addition, many patients discontinue their 
medication due to their side effects (Gerretsen et al. 2009). With additional 
information on the genetic profiles affecting these factors, it might be possible to 
achieve better treatment outcomes. Naturally, to be able to design treatment based 
on patients’ genetic profiles, additional genetic tests have to be created as well. 
Phenotypic assessment poses certain challenges for the studies of schizophrenia and 
other psychiatric disorders in comparison with other complex disorders like celiac 
disease and dyslipidemias. Schizophrenia is phenotypically very heterogeneous. The 
diagnosis is clinically based on a collection of various symptoms. Furthermore, 
schizophrenia symptoms are not at all specific for schizophrenia. They include many 
of the symptoms typical of other psychiatric disorders as well, and thus there is 
significant overlap in the phenotypic appearance. Most of the psychiatric disorders 
also seem to share a significant part of their genetic liability. It is often questioned if 
schizophrenia is an independent disorder or rather a group of disorders with highly 
similar phenotypes. It has been suggested that psychiatric disorders could be 
managed as a continuum of psychiatric symptom dimensions rather than strictly 
categorized independent diagnoses (van Os et al. 2009). Additional understanding of 
the genetic and patophysiological components underlying the symptoms of 
schizophrenia and other psychiatric disorders might eventually help in diagnostic 
classification and assessment (van Os et al. 2009, Korth 2009). Furthermore, it was 
recently suggested that some of the candidate genes for schizophrenia such as DRD2, 
APOE and NRG1 might provide blood biomarkers for psychosis (Kurian et al. 
2009). This might, in the future, enable more precise diagnosing and treatment of 
psychotic disorders. The future will show whether the genes of the DISC1 pathway 
can be utilized this way. 
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